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AMP Adenosine 5'-monophosphate 
AMPS Adenosine 5'-thiophosphate 
ATP Adenosine 5'-triphosphate 
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EDTA Ethylenediaminetetraacetate 
glucose-l-P glucose-l-phosphate 
IMP Inosine 5'-monophosphate 
MES 2(N-Morpholino)ethane sulfonic acid 
P^ Orthophosphate 
Tris Tris(hydroxymethyl)aminomethane 
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HISTORICAL BACKGROUND 
Glycogen phosphorylase (a-l,4-glucan : orthophosphate glycosyl 
transferase, E.(.2.4.1.1) catalyzes the Initial step in the degradation 
of glycogen; 
(a-l,4-glueoside)^ + $ (a-l,4-glucoside)^_^ + glucose-1-P. 
Although the equilibrium constant for this reaction is 0.3 at pH 6.8 (1), 
the enzyme acts in the direction of glycogen degradation in the cell due 
to the high ratio of inorganic phosphate to glucose-1-P (2). In 
muscle,the breakdown of glycogen is coupled to the energy needs of 
contraction, whereas in liver it is linked primarily to blood glucose 
homeostasis. 
The reaction sequence outlined above is an important control step 
in carbohydrate metabolism and glycogen phosphorylase has been shown 
to be part of a complex regulatory system involving several enzymes 
and the levels of substrates, divalent cations, nucleotides, and hormones. 
In addition, skeletal muscle phosphorylase has been suggested to be 
a reservoir for pyridoxal phosphate (3), which is an indispensable part 
of the enzyme (4), so that glycogen metabolism may also be affected by 
the nutritional intake of this vitamin. 
In 1943, Cori and Green reported that rabbit skeletal muscle glycogen 
phosphorylase exists in two forms, phosphorylase _a and phosphorylase ^  
(5). Subsequent studies have elucidated an interconversion mechanism 
involving the following phosphorylation-dephosphorylation sequence; 
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4 ATP 
phosphoxylasé b kinase 
phosphorylase a 2 phosphorylase ^  
phosphorylase phosphatase 
Phosphorylase a from skeletal muscle is a tetrameric enzyme composed of 
identical subunits (6). From sequence studies a monomeric molecular 
weight of 97,412 daltons has been determined (7). The phosphorylation 
site on the enzyme is a seryl residue located fourteen amino acids from 
the amino terminus (8). The £i form of the enzyme exhibits activity in 
the absence of an allosteric effector, although the activity is 
stimulated about 25% by AMP (9). The ^  form of the enzyme is a 
dimer (10), and exhibits an absolute requirement for a nucleotide 
activator (9). 
Although in the absence of any effectors phosphorylase a exists 
as a tetramer and phosphorylase ^  as a dimer, there exists a significant 
dimer-tetramer equilibrium for both forms. This equilibrium is 
dependent upon various factors including ionic strength, pH, temperature, 
and the presence of substrates and allosteric effectors (11). Huang 
and Graves have shown that the dimeric form of phosphorylase ^  is 
several fold more active than the tetramer (12). Under normal 
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physiological conditions both phosphorylases ^  and ^  exist as dimers. 
Phosphorylases a^ from several sources, e.g. lobster (13) and rabbit 
liver (14), exist only as dimers. 
Both the phosphorylation and dephosphorylation reactions are 
rigidly controlled. Fhosphorylase kinases from both skeletal muscle 
and liver have been shown to be activated via phosphorylation by 
cAMP-dependent protein kinase (15,16). Physiologically, this phosphor­
ylation is a result of hormonal stimulation. Fhosphorylase kinase can 
also be activated through an autophosphorylation mechanism initiated 
by the presence of calcium ions (17). This may be an important 
regulatory mechanism in skeletal muscle where nervous stimulation 
results in the release of calcium into the cytoplasm from the 
sarcoplasmic reticuluum. 
The controls on phosphorylase phosphatase activity have not been 
resolved to the same extent as those on the kinase. The substrate 
specificity of the phosphatase is apparently broader than that of 
phosphorylase kinase (18). Thus, one set of controls appears to be 
substrate competition for the enzyme. Hers and colleagues have 
suggested that this is important in the simultaneous inactlvation of 
phosphorylase and activation of glycogen synthase in vivo (19), and 
Witters and Avruch have also found evidence for this from studies 
utilizing perfused liver (20). 
Phosphatase activity is also regulated by the presence of various 
heat stable protein inhibitors (21-24). The presence of type I heat 
stable inhibitor is increased by epinephrine (25), suggesting that 
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both the phosphorylation and dephosphorylation of phosphorylase may 
be regulated by cAMP-dependent protein kinase. It has been suggested 
that the activity of phosphoprotein phosphatase is also regulated by 
glucocorticoids and insulin (26), thus providing further hormonal control. 
The metabolic interconversion of phosphorylase can also be 
regulated by substrate directed effects. The phosphorylation by 
phosphorylase kinase is inhibited by glucose-6-P and activated by 
glycogen. Both of these effects are mediated primarily by binding of 
the effectors to phosphorylase (27). The action of phosphoprotein 
phosphatase on phosphorylase is inhibited by AMP, and activated by 
caffeine, glucose, glycogen, and glucose-6-P. All these effects occur 
through binding to the phosphorylase molecule (28-31). 
Glycogen phosphorylase, which was originally purified from 
skeletal muscle, was shown to require AMP for activity (32). This 
was probably the earliest recognized example of allostery for an 
enzyme, and has been thought to have physiological Implications, both 
because AMP binds at physiologically relevant concentrations and 
because of the inhibition of AMP binding by Intracellular concentrations 
of ATP and glucose-6-P (11). More recent evidence suggests that increases 
in phosphorylase activity during exercise is not due to changes in ATP 
and glucose-6-P since the concentrations of these metabolites are not 
decreased under conditions where glycogen degradation is stimulated (33). 
Although AMP is the most proficient activator various other 
nucleotides (e.g. GMP and IMP) are able to activate phosphorylase to a 
significant extent (11). Allosteric activation by AMP results in a 
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lower for the substate, glucose-1-P, and an increase in the enzyme's 
maximal velocity. Binding of the nucleotide is a cooperative process 
showing both a homotropic interaction for nucleotide binding and a 
heterotropic cooperativity between nucleotide and substrate. The 
degree of cooperativity depends on a variety of factors, including 
buffer conditions, ionic strength, the nucleotide used as activator, 
and the presence of inhibitors. 
The locus of activator binding has been identified by x-ray 
crystallographic studies to be near the amino terminus of the molecule 
(34). This site has been found to be indiscriminate in the binding of 
phosphoryl ligands. The crystalline enzyme readily binds AMP, ADP, 
ATP, IMP, glucose-l-P, glucose-6-P, UDPG, fructose-l-P, and P^ (35). 
The importance of the phosphoryl portion of nucleotides in the activation 
process has been previously delineated from chemical studies (36). 
The recognition of phosphoryl groups appears to be through the basic 
pair, Arg 308, Arg 309 (35). Recognition of the aromatic base has also 
been emphasized, most notably by the ability of 8-(m-(-fluorosulfonyl-
benzamido))benzylthioadenine to activate through covalent modification, 
yet this analog does not contain a phosphoryl group, nor any anionic 
substituent (37,38). The use of this analog in the sequence determination 
of phosphorylase has located tyrosine 155 as the site of modification (7). 
Tyrosine 75 has also been localized in this region (39), and has been 
implicated in AMP binding since binding is abolished when this residue is 
modified by ferrate ion. Spectral studies have also implicated an 
interaction of the nucleotide activator with an aromatic residue (40,41). 
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Not all phosphorylase isozymes exhibit similar activation by 
nucleotides. Plant phosphorylases such as those isolated from 
potato (42) and maize (43) are not stimulated by AMP, nor is the 
enzyme isolated from yeast (44). Various mammalian isozymes, such as 
those from corpeus luteum (45), kidney (46), leukocyte (47), and liver 
(14), exhibit only slight activation in the presence of nucleotides. 
Liver phosphorylase ^  can be further activated with the inclusion of 
salts (48) or in the presence of high concentrations of glucose-l-P (49). 
Heart isozyme I exhibits a much greater inhibition of AMP binding by 
the competitive inhibitor, glucose-6-P, than does the enzyme from 
skeletal muscle (50). These studies suggest a metabolic adaptation of 
the nucleotide activation process. 
Although AMP has long been implicated as the physiologically 
important activator of skeletal muscle glycogen phosphorylase, recent 
experimentation by Rahim et al. (33,51), has suggested that IMP may be 
the actual regulator. Using phosphorylase kinase deficient mice it 
was found that, under stress conditions where the rate of glycogen 
degradation was increased, IMP concentration was elevated whereas that 
of AMP decreased slightly (51). These authors further found that the 
increased activity of phosphorylase under stress could not be accounted 
for by decreases in the concentrations of the inhibitors ATP and 
glucose-6-P, since the concentration of ATP stayed the same while that 
of glucose-6-P Increased. 
Early calorimetric studies suggested the presence of a second 
nucleotide binding site on phosphorylase (52). Recently, the location of 
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this site on phosphorylase a has been provided by crystallographlc 
studies and its kinetic characteristics determined (53). Nucleoside 
binding at this site Is competitive with glucose-l-P, which binds 10 & 
away. This site is approximately 30 X distant from the nucleotide 
activator binding site. Of the compounds capable of inhibiting 
phosphorylase by binding to this inhibitor site, the more hydrophobic 
compounds such as adenosine, caffeine, and riboflavin are more 
effective than the more hydrophilic nucleotides. Soman and Philip have 
shown that the ability of various aromatic compounds to inhibit 
phosphorylase is directly related to their hydrophobicity (54). The 
inhibition of skeletal muscle by purines or methylated oxypurines has 
been known since 1955 (55), although, until recently, it was thought 
that their action was indicated through the activator site. The nature 
of this inhibitor site has been shown by x-ray crystallographlc studies 
to be a hydrophobic slot between the side chains of Phe 285 and 
Tyr 612 (56). 
Binding at the two nucleotide binding sites on phosphorylase 
stabilizes different conformers of the enzyme. In the terminology 
of the Monod model (57), the T (tight) conformer is inactive and is 
stabilized by caffeine or glucose. The R (relaxed) conformer is active 
and is stabilized by AMP and substrates. The x-ray crystallographlc 
studies on phosphorylase have been undertaken on the inactive conformer, 
using glucose in the crystallization of phosphorylase ^  and IMP for 
phosphorylase^ (58,59). The conformational changes which take place 
during the T + R transition have been inferred by inducing the R form 
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with glucose-l-P in crystals which have been lightly crosslinked with 
glutaraldehyde (60). In the presence of glucose-l-P, the crystals 
crack but gradually reanneal. Significant structural changes are seen 
in residues 1-75, 103-124, 240-287, and 383-397. Although all these 
residues are in the amino terminal half of the molecule, they link 
all the major ligand binding sites. In the presence of UDPG (which also 
stabilizes the R conformer), Phe 285 moves about 5 %, thus eliminating 
binding capability at the nucleoside inhibitor site (35). The 
competitive inhibition seen by nucleoside binding at this site is 
thus explained by stabilization of an inactive enzyme conformer rather 
than a steric competition for binding. The same transitional changes 
result in helix 49-75 moving inward by about 5 thus possibly 
facilitating AMP stabilization of the R conformer by providing an 
interaction with Tyr 75 (35). 
The relative amounts of the two conformers depend on a variety of 
conditions other than those mentioned above. These include ionic 
strength, phosphorylation state, temperature, and the buffer used. 
The allosteric constant, L(L = T/R), varies from 6100 at 29° C to 0.05 
at 4° C (61). Phosphorylase in the absence of ligands, exhibits a 
ratio between 3 and 13 at 23° C (62). Thus, the activity in the 
absence of a nucleotide activator for the a form is probably a result of 
the stabilization of the active conformer through phosphorylation of 
the enzyme. 
Various authors have postulated additional conformational states in 
an attempt to explain apparent incongruities in their results with the 
Monod model. Kastenschmldt et (61) have suggested an additional 
state, to explain their results at low temperatures or low 
concentrations of AMP. They have suggested that this state is the 
dimeric form which associates to tetramers at low temperatures or 
high protein concentrations. Wang and Black (63) have also postulated 
an additional state in order to explain the effects of glucose and AMP 
! 
on phosphorylase ^  activation and dissociation. 
Although additional states may be necessary to explain various 
properties of phosphorylase, an alternative explanation may be that the 
incongruities arise due to alterations in the binding characteristics 
under certain conditions. Most of the major ligands for phosphorylase 
have been found to bind to more than one site on the enzyme (33) and 
their affinities towards the various binding sites may be dependent upon 
the experimental conditions, so that one molecule may stabilize different 
conformers under the proper conditions. 
The kinetic mechanism for phosphorylase has been suggested to be a 
rapid equilibrium random Bi-Bi based on studies utilizing phosphorylases 
a (.64,65) and b (66) from rabbit skeletal muscle, rabbit liver 
phosphorylase (67), and E. coli maltodextrln phosphorylase (68). The 
catalytic mechanism thus probably differs from that of sucrose 
phosphorylase which catalyzes a similar reaction. The kinetics for this 
enzyme are Ping-Pong and the reaction has been shown to proceed through 
a covalent glucosyl-enzyme intermediate (69-71). 1,5-Gluconolactone has 
been found to be a potent inhibitor of glycogen phosphorylase and this 
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has been interpreted to mean-that the transition state of the reaction 
is an oxonium ion in a half-chair conformation (72,73). 
X-ray crystallographic data, in conjunction with the sequence data, 
have provided information on the residues present in the active site 
region of phosphorylase (35,56,74). Two problems remain in using this 
information to provide a detailed description of the catalytic reaction. 
Refinement of the ctystal data to the precision necessary in order to 
provide exact orientation of the side chains has not been presented, 
and all the crystal data to date have been on the inactive T conformer; 
thus,the structure of the catalytic site for the active molecule still 
remains to be elucidated. The location of various residues in this 
region however does allow speculation on possible involvements in 
catalysis. From data for crystals obtained in the presence of glucose, 
Asn 133 is over the roof of the cavity, while Gly 135 and Leu 136 are 
closer above the glucose, and Leu 139 is toward the C-6 of glucose 
(35,56). These residues are part of the "glycine loop" (74) which 
extends from the nucleoside inhibitor site to the active site. This 
chain has been found to change orientations during the T -»• R 
transition (60). Asn 483 and Val 454 are also near the C-6 of glucose, 
while Gly 674, Ser 673, and Ala 672 are located in the region of the 
0-3 and 0-6. In the area around the C-1 carbon and the potential 
phosphate binding region are gound Asn 283, Asp 284, Arg 568, Tyr 572, 
and Glu 671 (33,56). 
Pyridoxal phosphate has been shown to be an essential component of 
glycogen phosphorylase since its discovery in the enzyme in 1957 (75). 
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Recently, Parrish et C76) showed that the pyrldoxal reconstituted 
enzyme was active in the presence of noncovalently bound phosphate or 
various phosphate analogs. These authors further showed that pyrophos­
phate was bound stoichiometrically, one mole per subunit, to the 
pyridoxal enzyme and competitively inhibited both the binding of the 
noncovalent phosphate and of the substrate, glucose-l-P, thus suggesting 
the presence of the pyridoxal phosphate at the catalytic site. This 
was confirmed soon afterward from crystallographic studies when the 
phosphoryl portion of pyridoxal phosphate was found to be within 7 & of 
the substrate phosphate (77). 
Removal of the pyridoxal phosphate results in an apoenzyme devoid 
of catalytic activity (78). Reconstitution of the apoenzyme with 
pyridoxal phosphate derivatives modified in positions 2, 3, and 6 have 
eliminated their possible involvement in the catalytic reaction (79-82). 
Reduction of the azomethine bond linking the pyridoxal phosphate to 
Lys 679 results in an enzyme which still retains essentially all of its 
activity (83). Thus the role of the coenzyme in phosphorylase must be 
different from that of the more classical Bg enzymes. A drastic change 
in the basicity of the pyridinium nitrogen, through the introduction of 
fluorine in position 6, still results in an active enzyme species, thus 
suggesting that it is also not directly • involved in catalysis (82). All 
recent attention has focused on the phosphoryl portion of the coenzyme 
and its potential involvement in catalysis. Various studies have 
indicated the necessity of a tetrahedral dianion at the 5 position 
(76,83-88). All other derivatives result in a total loss of enzymatic 
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activity. Helmreich and coworkers have shown, through P NMR studies, 
that a shift of the phosphorus resonance occurs upon activation of the 
enzyme (86,89). They have interpreted this as a deprotonation of the 
phosphoryl portion of the coenzyme and have suggested that this group 
donates a proton during the catalytic reaction. This appears to be 
inconsistent with the results of Parrish et al. (76) which showed that 
fluorophosphate was a good activator of the pyridoxal enzyme and yet 
this analog has a pK2 one and a half pH units below that of the phosphate 
of pyridoxal phosphate and thus would not be expected to be as readily 
involved in a protonation-deprotonation step under the same conditions 
as pyridoxal phosphate. 
Recently, Yan et al. (90) have shown that the dianionic form of 
the coenzyme is also necessary in order for various effectors at the 
active site and the nucleoside inhibitor site to be able to alter the 
rate of dephosphorylation of phosphorylase The state of the coenzyme 
did not appear to be important in order for effects on the dephosphory­
lation to be propagated through the nucleotide activator site. 
Various authors have estimated that, in skeletal muscle, between 
60% and 96% of the total vitamin in the tissue is associated with 
glycogen phosphorylase (3,91). Phosphorylase constitutes as much as 
5% of the soluble proteins in skeletal muscle (92), and muscle is 
approximately 40% of the total body mass. Therefore it has been 
suggested that phosphorylase constitutes a major reservoir for vitamin 
Bg in the body (3). Various studies have substantiated this idea. The 
specific activity of glycogen phosphorylase has been found to 
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substantially decrease in deficient animals (93,94). Black et al. 
(91) have recently reported that skeletal muscle phosphorylase activity 
and total Bg content increased steadily, in nearly a constant ratio, in 
rats fed a high level of pyridoxine over a six week period. Under the 
same conditions, there was only a slight increase in two other 
Bg containing enzymes, alanine and aspartate aminotransferases. These 
results suggest that glycogen phosphorylase meets criteria necessary for 
it being a reservoir for the vitamin. Black ^  (95) have 
further shown that another condition, starvation, is necessary for the 
initiation of phosphorylase depletion. 
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PART I. THE EFFECTS OF ORGANIC SOLVENTS ON THE CATALYTIC 
AND COENZYME PROPERTIES OF GLYCOGEN PHOSPHORYLASE 
15 
INTRODUCTION 
The activity of glycogen phosphorylase is controlled by an 
equilibrium between inactive and active conformations. The equilibrium 
is shifted towards an active form by substrates, phosphorylation, and 
the allosteric activator AMP (60-62). Early studies suggested that a 
second nucleotide binding site exists on phosphorylase (52) and x-ray 
crystallographic studies have shown that this site is located in a 
crevice of the protein some 30 & away from the AMP binding site (53). 
AMP does not bind effectively to this site but IMP, nucleosides, and 
purine analogs, e.g. caffeine and theophylline, do. Recent studies 
show that binding of these compounds competitively inhibits the binding 
of the substrate, glucose-1-P (53). This nucleoside binding site is 
distinct from that for glucose-l-P but in close proximity. Binding 
at this site stabilizes the inactive T conformation of the enzyme. 
Various techniques have been utilized in order to unravel the 
conformational changes involved in the T •> R transition, most recently 
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through x-ray crystallographic (60) and P NMR (86,96) studies, 
in order to gain insight into the catalytic mechanism and its controls. 
Organic solvents are found to also effect the allosteric equi­
librium of glycogen phosphorylase by shifting the equilibrium towards 
an active conformation. This report characterizes the properties of 
various phosphorylase isozymes in the presence of an organic solvent, 
1,2-dimethoxyethane, in order to further investigate the role of 
the allosteric equilibrium in the expression of catalytic activity. 
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The cofactor of glycogen phosphorylase, pyridoxal phosphate 
has been determined to be an indispensable component of the enzyme 
since its removal results in the loss of catalytic activity (78). 
Both structural (97-99) and catalytic (86,89) roles for the coenzyme 
have been suggested. The organic solvent 1,2-dimethoxyethane is also 
found to affect both the resolution and reconstitution roles of the 
coenzyme with phosphorylase Jb and apophosphorylase _b, respectively. 
Its use in the resolution of rabbit skeletal muscle phosphorylase 
is described in this report. Also described are further studies on 
the structural role of the coenzyme, especially that of the active 
site region of the enzyme. 
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EXPERIMENTAL PROCEDURES 
Preparation of Enzymes 
Rabbit skeletal muscle glycogen phosphorylasé ^  was prepared accord­
ing to the method of Fischer and Krebs (100) and recrystallized at least 
three times before use. Residual AMP was removed by treatment with Norite 
A. Rabbit liver glycogen phosphorylasé ^  was prepared as described by 
Appleman ^  (14). Muscle phosphorylasé a and liver phosphorylasé a 
were prepared from the respective phosphorylasé ^  forms by phosphorylation 
with rabbit skeletal muscle phosphorylasé kinase (101). Apophosphorylase 
^ was prepared according to Shaltiel ^  (102) and passed over a 
Sephadex G-25 column which had been equilibrated with 0.2 M imidazole and 
0.05 M L-cysteine at pH 6.0. Apophosphorylase ^  was prepared from phos­
phorylasé a by a modification of the method of Shaltiel et al. (102). The 
major changes were the inclusion of 10% (v/v) 1,2-dimethoxyethane in the 
resolution buffer and a higher incubation temperature (22°-23° C). Com- >. 
plete details of the procedure are presented under RESULTS. Phosphorylasé 
a reconstituted with pyridoxal phosphate analogs was prepared by incubating 
apophosphorylase ^  with a 5-fold excess of pyridoxal phosphate or a 25-fold 
excess of pyridoxal phosphate analogs in 40 mM ^-glycerophosphate, 30 mM 
2-mercaptoethanol at pH 6.8. After incubation for 30 minutes at 30° G, 
the reconstituted enzyme was precipitated by the addition of an equal 
volume of a neutralized saturated ammonium sulfate solution. The reconsti­
tuted enzyme was dialyzed extensively against 40 mM ^-glycerophosphate, 
30 mM 2-mercaptoethanol at pH 6.8 and recrystallized before use. 
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Preparation of [^^C]Glycogen 
[^^C]Glycogen was prepared in a 1 ml volume containing 50 mM 
[U-^^C]glucose-l-P (specific activity; 1 pCi/ymole), 3% glycogen, 
25 mM ^-glycerophosphate, 19 mM 2-mercaptoethanol, and 50 yg of 
phosphorylase ^  at pH 6.8. The reaction mixture was incubated for 19 
hours at 30° C and then cooled on ice. Protein was precipitated by 
the addition of 0.1 ml of 100% (w/v) trichloroacetic acid. The resulting 
suspension was centrifuged and the pellet was washed with 0.4 ml of cold 
10% trichloroacetic acid. The supernatant fractions were combined 
and the [^^C]glycogen was precipitated by the addition of absolute 
ethanol to a final concentration of 67%. The insoluble [^^C]glycogen 
was centrifuged and the resulting precipitate was redissolved in 1 ml of 
HgO. The ethanol precipitation was repeated three more times and the 
resulting [^^C]glycogen pellet was dissolved in 0.75 ml of HgO. The 
supernatant fraction of the final precipitation step contained less 
than 0.1% of the radioactivity of the insoluble fraction. 
Enzymatic Assays 
Phosphorylase activity in the direction of glycogen synthesis was 
measured either by the liberation of inorganic phosphate from 
glucose-l-P as described by Illingworth and Cori (103) or by the 
incorporation of [U-^^C]glucose into glycogen from glucose-l-P 
utilizing the filter paper assay of Thomas ^  (104). When the 
radioactive assay was used, absolute ethanol was substituted for acetone 
in the final wash. Unless otherwise specified, the assay system 
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contained 1% glycogen, 16 mM glucose-l-P, 20 mM ^-glycerophosphate, and 
15 mM 2-mercaptoethanol at pH 6.8 and 30° C. 1 mM AMP was also Included 
for the measurement of phosphorylase b activity. Activity is expressed 
as lU/mg, where 1 lU is 1 ymole of inorganic phosphate liberated or 
14 1 ymole of [U- C]glucose incorporated, per minute. 
In the direction of glycogen degradation utilizing [^^C]glycogen, 
the reaction conditions were as described in the figure legend in a 
total volume.of 0.04 ml. The reaction was terminated by the addition 
of 0.2 ml of cold 70% (v/v) ethanol. 0.02 Ml of cold nonradioactive 
10% glycogen was added and the suspension centrifuged. 0.1 Ml of the 
resulting supernatant was removed for the determination of radioactive 
glucose-l-P liberated. 
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P NMR Measurements 
31 
P NMR measurements were performed in collaboration with Dr. Paul 
Schmidt at the Oklahoma Medical Research Foundation, Oklahoma City, OK. 
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P Fourier-transformed NMR spectra were obtained at 109.4 MHz utilizing 
a 63.4 kilogauss Bruker superconducting magnet, a homebuilt detection 
transmitter/receiver, and a Nicolet 1180 computer and software. DgO was 
used for field/frequency lock. The sample tube was replaced with one 
containing phosphoric acid for chemical shift referencing. The 
appropriate experimental conditions are included in the figure legends. 
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Other Methods 
The extent of resolution of phosphorylase a or _b was tested by 
preincubating the apoenzyme, at 5 mg/ml, in the presence and absence 
of a 5-fold excess of pyridoxal phosphate at 30® C for 15 minutes. The 
resulting phosphorylase activity was measured by the method of 
Illingworth and Cori (103). The apoenzyme used in these experiments 
was better than 99% resolved and could be reconstituted to a specific 
activity comparable to the enzyme from which it was prepared. 
The extent of reconstitution with pyridoxal phosphate analogs 
was similarly determined by preincubating in the presence or absence 
of a 5-fold excess of pyridoxal phosphate. Reconstitution for all 
enzyme forms utilized in these experiments was found to be 100%. 
Phosphorylase concentrations were measured spectrophotometrically, 
1% 
using an extinction coefficient, at 280 nm of 13.2 (105). The 
monomeric molecular weight of phosphorylase was taken to be 97,400 
daltons (7). 
Sedimentation velocity experiments were performed with a Beckman 
Spinco Model E ultracentrifuge. The movement of protein boundaries 
was followed by Schlieren optics and the Schlieren patterns analyzed 
with a microcomparator. SgQ ^  values were calculated using a linear 
regression program of an HP-25 calculator. Viscosity measurements 
were performed using a Hewlett Packard Auto Viscometer Model #5901B. 
pK values were determined by the protocol of Alberty and Massey (106). 
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Values for the for substrates, the for activators, and the 
Hill coefficients (n^) for these effectors were determined either 
graphically or, more commonly, through the use of a linear regression 
program of an HP-25 calculator utilizing the equation for a Hill plot 
(107). The maximal velocities utilized in these plots were extrapolated 
graphically from plots of (initial velocity) ^ versus (effector 
concentration) Hill plots were used because of the significant 
curvature of the double reciprocal plots. 
Materials 
AMP, glucose-l-P, L-cysteine, pyridoxal, pyridoxal phosphate, 
caffeine, and ^-glycerophosphate were obtained from Sigma Chemical 
Company and used without further purification. Grade 1 imidazole 
from Sigma was used after three times recrystallization from reagent 
grade acetone. Shellfish glycogen from Sigma was further purified 
according to the method of Anderson and Graves (38). 2-Mercaptoethanol 
was obtained from Aldrich and [U-^^C]glucose-l-P from Amersham. 
1,2-Dimethoxyethane was obtained from Eastman Kodak. Phosphorous acid 
from Fisher Scientific Company was dried over phosphorus pentoxide, 
neutralized with sodium hydroxide, and used as sodium phosphite. 
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RESULTS 
Inhibition of the AMP-induced activation of rabbit skeletal 
muscle phosphorylase ^  by various hydrophobic compounds has been 
described by Anderson and Graves (38). Soman and Philip (54) have 
found a direct correlation between the ability of various aromatic 
compounds to inhibit phosphorylase and their hydrophoblcity. Recently, 
the binding of various hydrophobic compounds such as caffeine and 
adenosine to a nucleoside Inhibitor site on phosphorylase ^  has been 
described (53). The apparent hydrophobic nature of these binding sites 
has prompted the use of organic solvents to further examine the 
nucelotlde control of phosphorylase. 
A representative list of the organic solvents examined is presented 
in Table I. It was found that most of the solvents tested, which 
were miscible with water, resulted in an activation of the AMP-lnduced 
phosphorylase ^  activity, while the cyclic compounds tested, 
tetrahydrofuran and dloxane, inhibited the enzyme. The most pronounced 
activation was found to be with methyl ethers of glycols. There 
appeared to be no direct correlation between the extent of activation 
of phosphorylase and the dielectric constant of the medium (e.g. glycerol, 
which has a lower dielectric constant than water, inhibits while 
dimethyl sulfoxide, which at the concentration used does not significantly 
alter the dielectric constant, activates). However, most of the solvents 
which activate have lower dielectric constants than water. The inhibition 
seen by some of the compounds may be due to binding at one or more of 
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Table I. Activation of phosphorylase b by organic solvents* 
Solvent (10% v/v) Activity Ratio 
Water 1.00 
Methanol 1.22 
Ethanol 1.10 
Glycerol 0.87 
Ethyleneglycol 0.93 
Propyleneglycol 1.12 
2-methoxyethanol 1.28 
1,2-dimethoxyethane 1.34 
1,1-dlmethoxyethane 1.30 
Dimethoxymethane 1.24 
Trimethylorthoformate 1.24 
2-butoxyethanol 0.00 
Acetone 1.24 
Dimethylsulfoxide 1,24 
Tetrahydrofuran 0.16 
Dioxane 0.44 
13pg/ml of phosphorylase ^  was assayed in the presence of 16 mM 
glucose-1-P, 1% glycogen, 1 mM AMP, 10 mM ^-glycerophosphate, 7.5 mM 
2-mercaptoethanol and 10%(v/v) of the indicated solvents at pH 6.8 
and 30° C. The measurements were performed in duplicate and the data 
are presented as the average. The activity ratios for the two 
determinations varied less then 0.04. 
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the many sugar binding sites on phosphorylase since these compounds 
were used at relatively high concentrations and the inhibitory compounds 
contained hydroxyl groups or were cylic compounds with ring oxygens. 
Further studies were initiated with the most potent activator, 
1,2-dimethoxyethane, because preliminary results indicated that it was 
also effective in reducing inhibition by hydrophobic compounds. The 
effect of 10% (v/v) 1,2-dimethoxyethane on various kinetic parameters 
is summarized in Table II. Inclusion of the solvent increases the 
maximal velocity of phosphorylase ^  obtained in the presence of 1 mM AMP 
by 19%. The K^'s for the substrates, glucose-l-P and glycogen, were 
decreased slightly with the inclusion of 1,2-dimethoxyethane. The 
presence of this organic solvent also affects the cooperative 
interactions. The slight homotropic cooperativity usually seen for 
glucose-l-P binding in the presence of saturating AMP is eliminated 
when the solvent is included. 
The most dramatic effect of 1,2-dimethoxyethane has been found 
to be on the nucleotide binding parameters of phosphorylase. Recently, 
Madsen and coworkers have shown that, in addition to a nucleotide 
activator site, there is a nucleoside inhibitor site where binding 
is competitive with the substrate, glucose-l-P (53,60). Using 
phosphorylase these authors have suggested an interaction between 
nucleoside binding sites from a plot of log (v versus the log 
of caffeine concentration, where is the velocity at constant substrate 
concentration in the presence of caffeine and v^ is the velocity in the 
absence of the inhibitor. This plot yields a slope of -1.4. Figure lA 
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Table II. The effect of 1,2-dimethoxyethane on the kinetic parameters 
of phosphorylase _b 
Kinetic Parameter 
In the absence of 
1,2-dimethoxy­
ethane 
In the presence of 
10% 1,2-dimethoxy­
ethane (v/v) 
glucose-l-P^ (mM) 3 2 
n^ glucose-l-P^ 1.1 1.0 
(lU/mg) 62 74 
K^glycogen^(%) 0.019 0.013 
AMP*^ (yM) 79 8 
ng AMP^ 1.4 1.0 
caffeine® (mM) 0.3 1.8 
n^ glucose-l-P at 1.4 1.1 
^Measured in the presence of 1 mM AMP, 1% glycogen, 20 mM 
^-glycerophosphate, 10 mM 2-mercaptoethanol, 10 yg/ml enzyme and 
glucose-1-P concentrations between 1 and 15 mM at pH 6.8 and 30® C. 
^Extrapolated from plots of (velocity) ^  vs. (glucose-1-P) 
from a. 
Measured in the presence of 1 mM AMP, 16 mM glucose-1-P, 15 mM 
^-glycerophosphate, 11 mM 2-mercaptoethanol, 13 yg/ml enzyme and 
glycogen concentrations between 0.0025% and 0.0625% at pl^ 6.8 and 30° C. 
^Measured in the presence of 1% glycogen, 16 mM glucose-l-P, 15 mM 
^-glycerophosphate, 11 mM 2-mercaptoethanol, 13 yg/ml enzyme and AMP 
concentrations between 10 and 100 yM in the absence of 1,2-dimethoxy-
ethane or between 0.25 and 12.5 yM in the presence of 1,2-dimethoxy­
ethane at pH 6.8 and 30°C. 
^Measured in the presence of 1% glycogen, 1 mM AMP, 20 mM 
3-glycerophosphate, 15 mM 2-mercaptoethanol, 9 yg/ml enzyme, glucose-l-P 
concentrations between 2 and 10 mM, and caffeine concentrations between 
0 and 0.5 mM in the absence of 1,2-dimethoxyethane and between 0 and 7 
mM in the presence of 1,2-dimethoxyethane at pH 6.8 and 30°C. 
Figure 1. Caffeine inhibition of glycogen phosphorylase 
Enzymatic activity was measured as described by 
Illingworth and Cori (103) in the presence of 1% glycogen, 
1 mM AMP, 20 mM ^-glycerophosphate, 15 mM 2-mercaptoethanol, 
4 ng/ml of enzyme, glucose-l-P concentrations between 2 and 
10 mM, and caffeine concentrations of 0 (p), 0.1 mM (•) 
0.2 mM (a), 0.3 mM (•), and 0.5 mM (A), at pH 6.8 and'30° C. 
A. The experimental data are presented in the form of a 
double reciprocal plot. V is determined from the 
y-intercept. ™ 
A. (inset) The same data are presented in the form of 
a Hill plot for the determination of K . 
app 
B. Determination of the for caffeine inhibition. 
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shows the effect of caffeine on the kinetics of phosphorylase b with 
respect to glucose-l-P in the absence of added solvent. A large 
increase in cooperativity is seen with increasing caffeine. This could 
be due to either cooperative inhibitor binding or increased cooperativity 
of substrate binding in the presence of the inhibitor. A Hill plot of 
the same data shows that the Hill coefficient (n^) for glucose-l-P 
binding increases from 1.1 in the absence of caffeine to 1.7 at 0.5 mM 
caffeine. A replot of K /V versus the concentration of caffeine 
app m 
(Fig. IB) is linear. A of 0.3 mM for caffeine is determined from 
the X-intercept. 
Binding at the nucleoside inhibitor site facilitates the R •> T 
transition by stabilizing the T conformer (35,53). The lack of 
apparent cooperativity seen for binding to this conformer was further 
investigated using glucose which binds to the active site region of 
phosphorylase and also stabilizes the inactive T conformer (35,62). 
The data obtained for this inhibitor are similar to those obtained for 
caffeine (Fig. 2). A double reciprocal plot shows increasing 
cooperativity at increasing glucose concentrations. This is again 
attributable to substrate binding since the Hill coefficient for 
glucose-l-P increases from 1.1 in the absence of the inhibitor to 
1.9 an 15 mM glucose. Again a replot of versus inhibitor 
concentration is linear and a of 6 mM is determined. The Hill 
coefficient for glucose-l-P at the value for both inhibitors is 
the same, 1.4. 
Figure 2. Glucose inhibition of glycogen phosphorylase _b. 
Enzymatic activity was measured as described by 
Illingworth and Cori (103) in the presence of 1% glycogen, 
1 mM AMP, 20 mM ^-glycerophosphate, 15 mM 2-mercaptoethanol, 
4 yg/ml of enzyme, glucose-1-P concentrations between 2 and 
10 mM, and glucose concentrations of 0 (o), 3 mM (•), 
6 mM (o), 9 mM (•), 12 mM (A), and 15 mM (A) at pH 6.8 and 
30° C. 
A. The experimental data are presented in the form of a 
double reciprocal plot for the determination of V . 
m 
A. (inset) The same data are presented in the form of a Hill 
plot for the determination of K 
app 
B. Determination of the for glucose inhibition. 
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The effect of the inclusion of 10% (v/v) 1,2-dimethoxyethane on 
the binding parameters at the two nucleotide sites is summarized in 
Table II. The solvent exerts an opposite effect on the two sites. In 
the presence of the solvent, the for AMP is lowered 10-fold. The 
for phosphorylase b in the presence of 1,2-dlmethoxyethane is 
similar to that reported for phosphorylase a (62). The solvent also 
eliminates the apparent cooperativity seen for AMP binding. The 
presence of 1,2-dimethoxyethane causes a 6-fold increase in the for 
caffeine binding at the nucleoside inhibitor site. The solvent again 
exhibits an effect on the cooperative interactions of phosphorylase. 
The apparent cooperativity for glucose-l-P binding in the presence of 
the inhibitor is reduced. The Hill coefficient at the value decreases 
from 1.4 in the absence of organic solvent to 1.1 in the presence of 
10% (v/v) 1,2-dimethoxyethane. The data presented here are consistent 
with the organic solvent being able to alter the allosteric equilibrium 
since AMP binds with greater affinity to the R conformer (62) while 
caffeine appears to bind exclusively to the T conformer (35,53,96). 
In order to further investigate the effect of 1,2-dimethoxyethane 
on the allosteric equilibrium, its effect on the different forms of 
phosphorylase was investigated since phosphorylase a has a lower 
allosteric constant, i.e. a larger relative amount of the active R 
conformer (61,62). As is shown in Figure 3, the stimulation of 
phosphorylase activity by the organic solvent is highly dependent upon 
the enzyme's activity state. Phosphorylase b in the presence of 
saturating AMP and phosphorylase a in the absence of a nucleotide 
Figure 3. 1,2-Dimethoxyethane activation of glycogen phosphorylase. 
Enzymatic activity was measured as described under 
EXPERIMENTAL PROCEDURES in the presence of the indicated 
amounts of 1,2-dimethoxyethane. The assay mixture also 
contained: 
A. 13 yg/ml of rabbit skeletal muscle phosphorylase Jb in 
the presence of no nucleotide (o), 1 mM AMP (o), or 
1 mM IMP (A); 
B. 13 ug/ml of rabbit skeletal muscle phosphorylase a 
in the presence of no nucleotide (•) or 1 mM AMP (o); 
C. 15 yg/ml of rabbit liver phosphorylase ^  in the presence 
of no nucleotide (P), 5 mM AMP (o), or 5 mM IMP (A). 
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activator exhibit comparable maximal stimulations by the solvent of 35%. 
Phosphorylase ^  in the presence of 1 mM AMP has a maximal stimulation of 
only 9% in the presence of 1,2-dimethoxyethane. The effect of the 
solvent on the maximal velocities and the K 's for glucose-l-P for the 
m 
various enzyme forms is presented in Table III. The differences seen 
in the values for phosphorylase Jb between Tables II and III are due to 
the different enzyme preparations used as well as the different 
ranges of glucose-l-P concentrations utilized. At 10% (v/v) 
1,2-dimethoxyethane phosphorylase jb exhibits the largest effect of 
the solvent on both substrate binding and the maximal velocity. 
Phosphorylase a in the absence of AMP has a 13% stimulation of the 
maximal velocity as compared to 14% for phosphorylase _b in the presence 
of 1 mM AMP. However, phosphorylase ^  exhibits a smaller effect on 
substrate binding. Phosphorylase ^  in the presence of AMP shows a 
decrease in the maximal velocity in the presence of 10% (v/v) 
1,2-dimethoxyethane. This enzyme form also shows no effect of the 
solvent on glucose-l-P binding. 
The results on the parameters for nucleotide binding obtained with 
1,2-dimethoxyethane suggested that this organic solvent could serve 
as a useful probe to examine the different nature of these sites and 
possible controls of phosphorylase activity by differential binding at 
either an activator or inhibitor site on the same molecule. The 
different effects of 1,2-dimethoxyethane on the two nucleotide binding 
sites can be seen by using a single nucleotide, IMP (Fig. 3A). 
The IMP-induced activity increases from 1.9 lU/mg in the absence of 
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Table III. The effect of 1,2-dlmethoxyethane on kinetic constants for 
the different forms of rabbit muscle glycogen phosphorylase 
K- gluoose-l»i 
m 
(mM) V ^ 
max 
(lU/mg) 
% 1,2-dimethoxyethane 
(v/v) 
0 10 0 10 
Phosphorylase _b (-AMP) -50 6.4 2 14 
Phosphorylase _b (+AMP) 5.4 3.2 66 75 
Phosphorylase a. (-AMP) 3.8 3.2 53 60 
Phosphorylase a (+AMP) 2.7 2.7 73 68 
Measured in the presence of 1% glycogen, 20 mM ^-glycerophosphate, 
15 mM 2-mercaptoethanol, 4 yg/ml of enzyme, and glucose-l-P concentrations 
between 2 and 10 mM at pH 6.8 and 30° G whether in the presence or absence 
of 1 mM AMP as indicated for phosphorylase ^  (+AMP), phosphorylase a. 
(-AMP), and phosphorylase a (+AMP). For phosphorylase b (-AMP), the K 
was measured in the presence of 1% glycogen, 20 inM ^-glycerophosphate,™ 
15 mM 2-mercaptoethanol, 67 pg/ml of enzyme, and glucose-l-P 
concentrations between 10 and 160 mM at pH 6.8 and 30° C in the absence 
of 1,2-dimethoxyethane. In the presence of 1,2-dimethoxyethane the 
same enzyme form was assayed in the presence of 1% glycogen, 20 mM 
^-glycerophosphate, 15 mM 2-mercaptoethanol, 20 pg/ml of enzyme, and 
glucose-l-P concentrations between 1 and 15 mM at pH 6.8 and 30° C. 
^Extrapolated from plots of (velocity)"^ versus (glucose-l-P)"^ 
from a. 
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organic solvent to 46.1 lU/mg at 12.5% (v/v) 1,2-dimethoxyethane. IMP 
has about equal affinities for the nucleotide binding sites, 
Ki = Ka - 2 mM in the absence of added solvent (108), so that decreased 
binding at the inhibitor site and increased binding at the activator 
site is seen as the allosteric equilibrium is shifted with increasing 
concentrations of 1,2-dlinethoxyethane. At the highest concentrations 
of 1,2-dimethoxyethane, IMP activation of phosphorylase ^  is only 
slightly below that of AMP. These results are consistent with those of 
Black and Wang (109) which showed that, in the presence of high 
glucose-1-P, IMP activation was comparable to that of AMP. 
Figure 3C depicts the activity of rabbit liver phosphorylase ^  
in the presence of no nucleotide, 5 mM IMP, and 5 mM AMP with increasing 
concentrations of 1,2-dimethoxyethane. The activation patterns for 
the two nucleotides exhibit identical profiles. The profiles exhibit 
similar patterns at 1 mM nucleotide. The maximum activation by liver 
phosphorylase ^  by 1,2-dimethoxyethane in the presence of AMP or IMP is 
similar to the activity of liver phosphorylase ^  in the absence of 
nucleotide. Liver phosphorylase ^  activity is not stimulated by 
10% (v/v) 1,2-dimethoxyethane. 
Phosphorylase ^  activity is no longer as dependent on a nucleotide 
activator when the activity is measured in the presence of an organic 
solvent (Table III, Figs. 3A and 3C). For phosphorylase b activity 
measured in the absence of activators (AMP or 1,2-dimethoxyethane), 
the recrystallized enzyme was Norite A treated five times. No change 
in the ratio was observed for the last two treatments. The 
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enzyme used in the experiment in the absence of any activators had a 
specific activity of 40 lU/mg in the presence of AMP. The extent to 
which activation can be achieved in the absence of AMP using 
1,2-dimethoxyethane is shown in Figure 4. AMP activation has been 
reported to be characterized primarily by a decrease in the for 
substrates (110). Activation by 1,2-dimethoxyethane in the absence of 
nucleotides, is characterized by a change in the maximal velocity 
between 10% and 20% (v/v) 1,2-dimethoxyethane, with only a slight change 
in the affinity for the substrate. Dreyfus ^  al. (Ill) have also 
recently investigated the action of organic solvents on phosphorylase ^  . 
These authors reported that at lower concentrations of organic solvent 
there was an increase in substrate binding, the for glucose-l-P being 
lowered from 11 to 2.3 mM as the t-butanol concentration was raised from 
5 to 10%. The for glucose-l-P would be expected to be changing at 
lower concentrations of 1,2-dimethoxyethane also since the substrate 
affinity of phosphorylase ^  in the absence of activators is much higher 
than that seen in the presence of 10% (v/v) 1,2-dimethoxyethane. The 
maximal velocity obtained at the highest solvent concentration used is 
46 lU/mg or 74% of that obtained in the presence of saturating AMP. 
No activity measurements were performed at concentrations of 
1,2- dimethoxyethane higher than 25% because at these concentrations 
glycogen was precipitated. Another property of nucleotide activators 
which was also found to be characteristic of organic solvent activation 
was the reduction of homotropic cooperativity for the substrate. 
The Hill coefficient decreases from 1.6 to 1.0 as the concentration of 
Figure 4. 1,2-Dimethoxyethane activation of phosphorylase ^  in the 
absence of nucleotides. 
Activity was measured according to Illingworth and Cori 
(103) in the presence of 1% glycogen, 20 yg/ml of phosphorylase 
b, 20 mM ^-glycerophosphate, 15 mM 2-mercaptoethanol, 10% 
(O), 15% (o), or 20% (A) (v/v) 1,2-dimethoxyethane, and the 
indicated amounts of glucose-l-P at pH 6.8 and 30° C. 
0.2 0.'  
[glucose-l-P]"^ 
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1,2-dimethoxyethane increases from 10% to 20%. A plot of the reciprocal 
of the maximal velocity versus the reciprocal of the 1,2-dimethoxyethane 
concentration exhibits significant curvature similar to the cooperativity 
seen for AMP activation. Since, as mentioned above, the higher 
concentrations of 1,2-dimethoxyethane could not be used, neither the 
for solvent activation nor the maximal velocity obtainable for saturating 
solvent effect could be determined. 
Dreyfus et al. (Ill) have reported that t-butanol affects the 
aggregation state of phosphorylase _b in the presence of AMP. The 
effect of organic solvents on the dissociation-association properties 
of phosphorylase has been further examined in order to investigate 
whether the effects of these solvents on the activity properties could 
be explained by an alteration of this equilibrium. Phosphorylase 
exists as either a dimer or tetramer depending on the state of 
phosphorylation and the presence of various effectors of the enzyme. 
Under the buffer conditions utilized in most of these experiments, 
phosphorylase ^  sediments as a dimer and phosphorylase ^  as a tetramer 
both in the presence and absence of 1,2-dimethoxyethane (Figure 5A and 
5B). In the presence of AMP, phosphorylase ^  sediments primarily as a 
tetramer at 10° G although a significant amount of dimer is still 
present (Figure 5C). With the inclusion of the solvent this profile is 
shifted totally towards the tetramer in agreement with the results of 
Dreyfus et al. (111). The slight difference in the rates of 
sedimentation for the dimer and tetramer in the presence of the solvent 
can be explained by a change in the viscosity of the solution due to 
Figure 5. The effect of 1,2-dimethoxyethane on the aggregation properties 
of glycogen phosphorylase. 
Sedimentation velocity experiments were performed as 
described under EXPERIMENTAL PROCEDURES at 52000 rpm. 
A. The sample contained 4,0 mg/ml of phosphorylase ^  in 
36 mM ^-glycerophosphate, 27 mM 2-mercaptoethanol at 
pH 6.8 in the absence (top) or presence (bottom) of 
10% (v/v) 1,2-dimethoxyethane. The run was performed 
at 10° C. S^Q ^  values are 8.3s (top) and 8.4s (bottom). 
B. The sample contained 3.9 mg/ml of phosphorylase a in 
36 mM ^-glycerophosphate, 27 mM 2-mercaptoethanol at pH 
6.8 in the absence (top) or presence (bottom) of 
10% (v/v) 1,2-dimethoxyethane. The run was performed 
at 21° C. SgQ ^ values are 12.2s (top) and 12.8s (bottom). 
C. The sample contained 3.7 mg/ml of phosphorylase ^  in 
1 mM AMP, 36 mM g-glycerophosphate, 27 mM 2-mercaptoethanol 
at pH 6.8 in the absence (top) or presence (bottom) of 
10% (v/v) 1,2-dimethoxyethane. The run was performed 
at 10° C. SgQ ^  values are 12.6s (top) and 13.1s (bottom). 
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the presence of the solvent. Inclusion of 10% (v/v) 1,2-dimethoxyethane 
results in a 36.8% increase in the viscosity of the solution at 10° C. 
Using phosphorylase a., the effect of 10% (v/v) 1,2-dimethoxyethane 
on the specific activities of both the dimeric and tetrameric forms 
of this enzyme was examined as well as the effect of the solvent on 
the dimer-tetramer equilibrium under the normal assay conditions. 
Huang and Graves (12) have shown that both the dissociation constant 
for this equilibrium and the specific activities for the two forms 
can be determined from activity measurements. Figure 6A shows the 
specific activity of phosphorylase ^  as a function of protein 
concentration. As can be seen, the curve differs slightly when 
1,2-dimethoxyethane is included in the assay. Figures 6B and 6C 
show extrapolations to obtain the specific activities of the dimer and 
tetramer, respectively. The plot for Figure 6B is from the equation (12); 
 ^ 7 X E^ (i - <j.^ ) + 1 
* - «tj) -
where ^  = measured specific activity, (j)^ = = total enzyme 
concentration, and = specific activity of the dimer. Figure 6B shows 
that there is a slight difference for the specific activity of the dimer 
due to the presence of the solvent. This increase of the specific activ­
ity of the phosphorylase a^ dimer amounts to about 6% under these condi­
tions. The curvature from the squared term of the above equation is most 
evident in the absence of added solvent, thus providing difficulty in 
obtaining accurate values for and K^. The differences due to the 
Figure 6. The effect of 1,2-dimethoxyethane on the specific activity 
of phosphorylase. 
A. Activity was assayed as described under EXPERIMENTAL 
PROCEDURES in the presence of 1% glycogen, 18 mM 
^-glycerophosphate, 0.9 mM EDTA, 0.5% KCl and the 
indicated amounts of phosphorylase ^  at pH 6.8 and 
24° C in the absence (P) or presence (•) of 10% (v/v) 
1,2-dimethoxyethane. For enzyme concentrations below 
0.5 mg/ml, 0.5 mg/ml boxine serum albumin was also 
included in the assay. 
B. The data from A are plotted as (<() - (|)j) ^ versus 
[E^($ - 4^)] in order to obtain (|)^ and K^. 
C. The data from A are plotted as <j) versus (E ) ^ in order 
to obtain <|)^ . 
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presence of 1,2-dimethoxyethane thus may be actually less than estimated 
here. The results suggest that there is little change in the 
dissociation constant for the dimer-tetramer equilibrium, the being 
increased from 7.8 x 10 to 9.1 x 10 g/1 due to the inclusion of 
10% (v/v) 1,2-dimethoxyethane. The tetramer, which under the conditions 
used here has about 10% of the activity of the dimer in the absence of 
1,2-dimethoxyethane, exhibits a much larger stimulation due to the 
presence of the solvent. As can be determined from Figure 6C,this 
stimulation is approximately 60%. Since 1,2-dimethoxyethane affects 
the specific activities of both the dimeric and tetrameric forms of 
phosphorylase a while doing little to alter the dissociation constant, 
it seems unlikely that the changes seem in the activity properties 
of the enzyme could be explained by large changes in the enzyme's 
aggregation state. 
Further evidence that the organic solvent activates by shifting the 
allosteric equilibrium is presented in Figure 7. The model of Monod 
et al. (57) predicts that for allosteric inhibitors which bind to the 
R form, activation should be seen at low concentrations of these 
inhibitors. ATP, an allosteric inhibitor of phosphorylase (11), 
inhibits the AMP activation of phosphorylase _b, probably via direct 
competition for the AMP site. In the presence of 10% (v/v) 
1,2-dimethoxyethane, ATP serves to activate the enzyme. Both experiments 
were performed at the for AMP under the respective conditions 
(Table II). The apparent lack of inhibition for the 1,2-dimethoxyethane 
Figure 7. The effect of 1,2-dJjnethoxyethane on ATP inhibition of 
phosphorylase ^  activity. 
Enzymatic activity was measured as described by 
Illingworth and Cori (.103) in the presence of 1% glycogen, 
16 mM glucose-l-P, 15 mM ^-glycerophosphate, 11 mM 
2-mercaptoethanol at pH 6.8 and 30® C in the presence of 
80 yM AMP (o) or 8 yM AMP and 10% (v/v) 1,2-dimethoxyethane 
(•) at the indicated concentrations of ATP. 
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Induced activity further suggests the presence of an "^-like" molecule 
since phosphorylase a is not effectively inhibited by ATP (11). 
The effect of 1,2-dimethoxyethane on the pH profile of glycogen 
phosphorylase ^  was undertaken in order to further investigate the 
mechanism by which the enzyme is allosterically activated by the solvent. 
As can be determined from Figure 8A there is little effect of the solvent 
on the alkaline limb of the pH profile. Kasvinsky and Meyer (112) 
have suggested that this ionization is that of a histidyl group based 
on the observed pK^ and heat of ionization. This assumption is also 
consistent with the fact that the pK^ is not perturbed by a possible 
environmental change induced by the presence of the organic solvent. 
The acidic limb of the pH profile exhibits a pronounced dependency 
on the environment. The pK.^ is shifted due either to the presence 
of the solvent itself or to a conformational change induced by the 
solvent. The change in the pH profile for the AMP-activated 
phosphorylase ^  in the presence of 1,2-dimethoxyethane cannot be 
explained by a change in the pK^ of the substrate due to the presence 
of the solvent, since in the absence of AMP, the 1,2-dimethoxyethane-
induced profile appears to have a similar pK^ to nonactivated 
phosphorylase b (Fig. 8B). The differences in the profiles are also 
not due to a perturbation of the buffer pH by the solvent, since as is 
seen in Figure 8C the same shift in the acidic limb is seen in 
Tris-Imidazole buffer. As was mentioned above, the ionization of 
imidazole should not perturbed by the presence of organic solvents. 
Apparently, the changes seen here are due a perturbation of the 
Figure 8. The effect of pH on the stimulation of phosphorylase ^  
activity by 1,2-dimethoxyethane. 
Enzymatic activity was measured according to Illingworth 
and Cori (103) in the presence of 1% glycogen and 50 miM 
glucose-1-P at the indicated pH values and at 30° C. The 
presence of other substances were as indicated. Both 
substrates and buffers were adjusted to the indicated pH 
values. 
A. 16 yg/ml of phosphorylase ^  was assayed as described 
above in the presence of 50 mM Tris-maleate, 10 mM AMP 
for the pH values of 5.6 to 6.2, 3 mM AMP for the pH 
values of 6.4 to 8.0, in the absence (•) or presence 
(•) of 10% (v/v) 1,2-dimethoxyethane. 
B. 49 yg/ml of phosphorylase _b in the presence of 
10% (v/v) 1,2-dimethoxyethane (A), or 3 mg/ml 
phosphorylase ^  in the absence of 1,2-dimethoxyethane 
(o), was assayed as described above in the presence of 
50 mM Tris-maleate. 
C. Assay conditions were as described in A with the 
substitution of 50 mM Tris-50mM imidazole for thé 
Tris-maleate buffer. 
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ionization of some residue on the enzyme which is Important for the 
catalytic reaction rather than the binding of substrates of activators, 
since the concentrations of all effectors used here should be saturating 
according to the results reported by Kalvinsky and Meyer (112) and 
Hollo et (113). 
As has been alluded to earlier, the presence of the organic 
solvent affects the binding of effectors to the active site. The 
binding of the substrates, glucose-l-P and glycogen, are slightly 
improved in the presence of AMP, while the binding of the inhibitor, 
glucose, is significantly reduced, the being increased from 6 mM 
to 21 mM with the inclusion of 10% (v/v) 1,2-dimethoxyethane. Since 
as was mentioned earlier, glucose binds to and stabilizes the inactive 
T conformer (35,62), the decreased affinity under conditions where 
the R conformer is further stabilized is not surprising. 
Figure 9A shows the effect of 1,2-dimethoxyethane on the inhibition 
by 1,5-gluconolactone. This compound has been suggested to be a 
transition analog for the phosphorylase reaction (72,73). The increased 
inhibition by this compound in the presence of the solvent cannot be 
explained by a change in the rate of its hydrolysis since, as is seen 
in Figure 9B, the inclusion of 1,2-dimethoxyethane actually accelerates 
this process. The increased inhibition by this compound is suggestive 
of a more stabilized transition state under conditions where the 
maximal velocity is also increased. 
Bunton and coworkers (ll4,115) have provided evidence the acid 
hydrolysis of glucose-l-P proceeds through an S^l mechanism via an 
Figure 9. The effect of 1,Z-dijnethoxyethane on the inhibition of 
phosphorylase ^  activity by 1,5-gluconolactone. 
A. Assay conditions were as described under EXPERIMENTAL 
PROCEDURES in the presence of 13 yg/ml phosphorylase 
no (p) or 10% (•) (v/v) 1,2-dlmethoxyethane and the 
indicated amounts of 1,5-gluconolactone. 
B. The effect of 1,2-dimethoxyethane on the hydrolysis of 
1,5-gluconolactone. 3 mM gluconolactone was incubated 
in the presence of 40 mM ^-glycerophosphate and no (•) 
or 10% (°) (v/v) 1,2-dimethoxyethane at pH 6.8. At 
the indicated times, aliquots were removed and hydrolysis 
determined as in Tu et al. (72). 
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oxonlum intermediate through the pH range 2 to 4, thus providing an 
analogy with the phosphorylase reaction. Below this range, there is 
an increase in rate which is not correlatable with the increase in 
hydrogen ion concentration (115). Tu et al. (72) have shown an isotope 
effect, kjj/k^, of 1,13 for the hydrolysis of glucose-l-P in 1.1 N HCl. 
This is also suggestive of an S^l mechanism. Figure 10 depicts the 
rate of hydrolysis of glucose-l-P in 1.2 N HCl as a function of chloride 
concentration. The rate exhibits a near linear dependency on the 
salt concentration as well as a further stimulation by the organic 
solvent, 1,2-dimethoxyethane. Bunton and coworkers have previously 
reported a salt effect on the hydrolysis of glucose-l-P (115) and from 
their work or electrolyte effects an acid-catalyzed ester hydrolyses 
(116) have suggested that the carbonium intermediate is stabilized by 
an increase in water activity as well as by specific salt interactions. 
Although the effect of salts has been shown previously, the data in 
Figure 10 are presented because the conditions used are similar to those 
showing the kinetic isotope effect (72) and also to present the effect 
of a lower dielectric on this process. 
Shaltiel ^  (102) found that pyridoxal phosphate could be 
resolved from phosphorylase ^  under mild conditions using a deforming 
buffer, imidazolium citrate, and a stereospecific aldehyde trapping 
agent, L-cysteine. Incubation of the enzyme with imidazodium citrate 
resulted in the formation of monomers and a rapid rate of exchange 
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with exogenous [ P]pyridoxal phosphate. These authors further reported 
that phosphorylase ^  could not be resolved under these conditions. Other, 
Figure 10. The effect of ionic strength and dielectric constant on 
the acid hydrolysis of glucose-l-P. 
200 mM glucose-l-P was Incubated in 1.2 N HCl with 
the concentration of chloride anion adjusted to the 
indicated levels by addition of KCl. The reaction was 
carried out in the absence (O) or presence (•) of 
10% (v/v) 1,2-diinethoxyethane (dielectric constant - 13) 
at 30° C. At intervals between 5 and 45 minutes, aliquots 
were removed and phosphate determined in a manner analogous 
to that utilized for the phosphorylase reaction (103). 
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more drastic, conditions have been utilized in the resolution of the 
cofactor from a form of the enzyme (79). However, these conditions 
result In an apophosphorylase ^  which can only be reconstituted to 
about half of the original activity. 
It was found that Inclusion of 10% (v/v) 1,2-dlmethoxyethane In 
the resolution medium accelerates the rate of resolution of phosphorylase 
The faster rate can be attributed to the increased accessibility 
of the pyridoxal phosphate (Figs. IIA and llB). In the presence of 
0.4 M Imidazollum citrate, but in the absence of L-cystelne, there is 
a gradual appearance of the 415 nm band of the bound pyridoxal phosphate. 
This band has been attributed to the exposed protonated Imine (117). 
The presence of 10% (v/v) 1,2-dimethoxyethane results in a large 
acceleration in the rate of appearance of this band. The process 
observed is not due to resolution of the cofactor since it was found 
that no loss of enzymatic activity occurs under these conditions. 
Shaltiel ^  (102) suggested on the basis of exchange experiments 
that the effect of the deforming buffer was to expose the coenzyme. 
However, no data have been presented previously which correlate this 
hypothesis with spectral evidence. 
Figure 12 demonstrates that the presence of 1,2-dimethoxyethane 
also results in an acceleration in the reverse reaction. The change 
in the reconstitution rate may be due to a change in the aggregation 
state of the enzyme since apophosphorylase h exhibits an increased 
predominance of the lower molecular weight forms in the presence of the 
solvent [Fig. 12 (inset)]. 
Figure 11. The effect of the resolution conditions on the spectral 
properties of pyridoxal phosphate bound to phosphorylase _b. 
9 mg/ml of phosphorylase Jb was incubated in the presence 
of 0.4 M imidazolium citrate, 42 mM 3-glycer6phosphate, 
9 mM 2-mercaptoethanol at pH 6.0 in the absence (A) or 
presence (B) of 10% (v/v) 1,2-dimethoxyethane. At the times 
indicated by the numbers on the curves, spectra were recorded 
on a Gary 15 recording spectrophotometer. 
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Figure 12. The effect of 1,2-dimethoxyethane on the rate of 
reconstitution of phosphorylase ^  with pyridoxal phosphate. 
5 mg/ml of apophosphorylase jb was incubated in the 
presence of 50 yM pyridoxal phosphate, 30 mM 
^-glycerophosphate, 23 niM 2-mercaptoethanol at pH 6.8 and 
19° C in the absence C°) or presence (•) of 10% Cv/v) 
1,2-dimethoxyethane. At the indicated times aliquots 
were removed and assayed as described under EXPERIMENTAL 
PROCEDURES. 
(inset) The effect of 1,2-dimethoxyethane on the aggregation state 
of apophosphorylase 
Sedimentation velocity experiments were performed as 
described under EXPERIMENTAL PROCEDURES at 52000 rpm. The 
sample contained 2.5 mg/ml of apophosphorylase ^  in 36 mM 
^-glycerophosphate, 27 mM 2-mercaptoethanol at pH 6.8 in 
the absence (top) or presence (bottom) of 10% (v/v) 
1,2-dimethoxyethane. The run was performed at 20° C. 
^20 w values are 8.2s and 18.0s (top) and 8.5s (bottom). 
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Since inclusion of the solvent resulted in an increased rate of 
resolution of the ^  form of phosphorylase, the possibility of its use 
in the resolution of phosphorylase a was investigated. From Figure 
13 it can be seen that no resolution of phosphorylase a is seen at 30° C 
under the resolution conditions described by Shaltiel et (102). 
Inclusion of 10% (v/v) 1,2-dlmethoxyethane results in a rapid loss of 
activity which has been found to be due to resolution of the coenzyme 
since incubation of pyridoxal phosphate, upon removal of the resolution 
buffer, results in a return of the enzymatic activity. Shaltiel et al. 
(102) have suggested that formation of monomers may be a prerequisite 
for resolution of the coenzyme based upon the finding that phosphorylase 
^ formed monomers in the presence of the deforming buffer. As is seen 
in Figure 13 (inset), the results obtained with phosphorylase a are 
also in agreement with this suggestion. In the presence of the deforming 
buffer alone, phosphorylase ^  sediments predominantly as the dimer and 
is not capable of being resolved. When the deforming buffer contains 
10% (v/v) 1,2-dimethoxyethane, conditions under which the enzyme would 
be resolved if L-cysteine were included, the enzyme sediments as a 
monomer. 
Good preparations of apophosphorylase SL can be prepared directly 
from phosphorylase a by modification of the procedure of Shaltiel et al. 
(102). Phosphorylase ^  at 5 mg/ml is incubated for approximately 12 
hours at room temperature (22°-23° C) in the presence of 0.4 M 
imidazolium citrate - 0.1 M L-cysteine - 10% (v/v) 1,2-dimethoxyethane 
at pH 6.0. The solvent is added to the deforming buffer immediately 
Figure 13. The effect of 1,2-dtmethoxyethane on the resolution of 
phosphorylase a. 
1.3 mg/ml of phosphorylase a was incubated in the 
presence of 0.4 M imidazolium-citrate, 0.1 M L-cysteine at 
pH 6.0 and 30° C in the absence (O) or presence (a) of 
10% (v/v) 1,2-dimethoxyethane. At the indicated times 
aliquots were removed and assayed as described under 
EXPERIMENTAL PROCEDURES. 
(inset) The effect of the resolution buffer on the aggregation 
state of phosphorylase a. 
Sedimentation velocity experimentation was performed 
as described under EXPERIMENTAL PROCEDURES at 52000 rpm. 
The sample contained 3,5 mg/ml phosphorylase ^  and 0.4 M 
Imidazolium-citrate at pH 6.0 in the absence (top) or 
presence (bottom) of 10% (v/v) 1,2-dimethoxyethane. The 
run was performed at 23° C. S._ values are 9.5s (top) 
and 4.2s (bottom) . 
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before use in order to minimize the precipitation of salts. After the 
incubation period, an equal volume of neutralized saturated ammonium 
sulfate is added and the suspension centrifuged. The precipitate is 
dissolved in 0.2 M imidazolium citrate - 0.05 M L-cysteine at pH 6 and 
desalted over Sephadex G-25 which had been preequilibrated with the 
same buffer. The protein-containing fractions are combined, made 50% 
saturated ammonium sulfate, and the precipitate is dissolved in 0.04 M 
3-glycerophosphate - 0.03 M 2-mercaptoethanol at pH 6.8. and dialyzed 
against the same buffer. The protein crystallizes when dialyzed in the 
cold. The resulting apoenzyme preparation is greater than 99% resolved 
based on activity and can be reconstituted, at 5 mg/ml phosphorylase 
with a 5-fold molar excess of pyridoxal phosphate, to the same specific 
activity as the phosphorylase a from which it is prepared. The 
reconstituted enzyme has the same properties as native phosphorylase a 
as determined by sedimentation characteristics, enzymatic activities, 
and as a substrate for a phosphoprotein phosphatase (90), The yield of 
apophosphorylase _a is routinely greater than 75%. Higher incubation 
temperatures during the resolution result in lower yields, even at 
shorter Incubation times. Higher incubation temperatures also result in 
a lower specific activity for the reconstituted enzyme. Lower incubation 
temperatures greatly decrease the rate of resolutions. 
Feldmann and Hull (86) have reported a line width of 55-60 Hz for 
31 
the P NMR signal of the pyridoxal phosphate bound to phosphorylases 
a and b. The line width of 20 Hz for the serine phosphate of 
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apophosphorylase a (Fig. 14A) suggests that this is much less rigidly 
fixed. The signal position corresponds to the dianion when compared to 
a peptide serine phosphate (Fig. 15). Hoerl et al. (118), using thio-
phosphorylated phosphorylase a, reported a line width and peak position 
for the thiophosphorylated serine corresponding to that of a dianion 
fixed in a salt linkage. The flexibility of the serine phosphate in 
the apoenzyme compared to the native is consistent with results on 
the trypsin sensitivity of this portion of the molecule (119) and the 
increased dephosphorylation rate for the apoenzyme (90). The accessi­
bility of the serine phosphate is further emphasized in Figure 15. 
The serine phosphate of the apoenzyme exhibits a pH titration profile 
similar to that of the tetradecapeptide corresponding to the region 
around this residue for the pH range 6.0-7.5. Spectra could not be 
obtained at lower pH values due to denaturation of the protein. 
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For pyridoxal reconstituted phosphorylase ^  the P NMR signal 
exhibits considerable line broadening when compared to the apoenzyme 
(Fig. 14B). Although this spectrum constitutes less than one half the 
number of scans as that of the apoenzyme, it is quite evident that 
even at an equivalent number of scans the peak would be broadened. 
This result suggests a more structured amino terminal region for the 
pyridoxal enzyme. A more structured conformation for this enzyme 
derivative has been previously suggested on the basis of hybrid 
enzyme (97) and spectral (.98,99) studies. 
The structural role for the coenzyme was further investigated using 
activity measurements. The unorganized structure for the amino terminal 
Figure 14. The effect of the coenzyme on the structure of phosphorylase 
a as determined by NMR spectra of the serine phosphate. 
A. Apophosphorylase ^  at 30 mg/ml in 50 mM Tris, 30 mM 
2-mercaptoethanol, and 0.3 M NaCl at OH 7.5. The 
spectrum represents 24,552 scans with an acquisition 
time of 0.20 sec and a pulse width of 24 ysec. The 
spectrum was obtained at 24° C. 
B. Pyridoxal reconstituted phosphorylase ^  at 38 mg/ml 
in 50 mM Tris, 30 miM 2-mercaptoethanol, and 0.4 M 
NaCl at pH 7.5. The spectrum represents 10,000 scans 
with an acquisition time of 0.20 sec and a pulse width 
of 24 ysec. The spectrum was obtained at 24° C. 
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Figure 15. pH Titration of the phosphoserine of a tetradecapeptlde 
and apophosphorylase ^  using NMR. 
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P NMR spectra of apophosphorylase ^  C*) were 
obtained using the same conditions as those described in 
Figure 14. The pH was adjusted with acetic acid. The 
points represent the peak position obtained from spectra 
for 24,552 scans at pH 7.5 and 10,000 scans at the lower 
pH values. NMR spectra for the tetradecapeptlde 
(NH2-SerAspGlnGluLysArgLysGlnlleS er(PO4)Valj^gGlyLeu-COOH) 
(o) were obtained in the presence of 0.24 mM peptide and 
50 mM imidazole at 24° C. The initial pH was 4.2 and the 
pH was adjusted to other pH values by the addition of 2 M 
Tris base. The points represent the peak positions 
obtained for 1,000 scans with an acquisition time of' 0.20 
sec. and a pulse width of 24 psec. 
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region of the apoenzyme suggests that the absence of activity for this 
form may be due to a low affinity for substrates. Figure 16A presents 
the activity as a function of phosphate concentration for native 
phosphorylase ^  and a 400-fold excess of an apophosphorylase _a 
preparation which was greater than 99.95% resolved. Activity was 
measured in the direction of glycogen degradation since Parrish ^  al. 
(76) have shown that the presence of noncovalent phosphate or phosphate 
analog is necessary for the expression of activity for pyridoxal-reconsti­
tuted phosphorylase. The results obtained here exhibit similar profiles 
for the apo and native enzymes, suggesting that the low activity of the 
apoenzyme is probably due to residual native phosphorylase No 
significant difference is seen in the profiles even at phosphate 
concentrations as high as 0.05 M. 
Honikel and Madsen (120) have reported that the iodide quenching 
of pyridoxal phosphate fluorescence is eliminated for phosphorylase ^  
in the presence of AMP and glucose-l-P together, thus suggesting that 
the coenzyme is inaccessible in the presence of substrate. This is 
further suggested from the results of Helmreich and Klein (89). These 
authors reported that, for coli maltodextrin phosphorylase, the 
ability of the phosphoryl portion of the coenzyme to be titrated is 
lost in the presence of the active site inhibitor, glucose. These 
results suggest that the ability of glucose-l-P to bind to the pyridoxal 
enzyme in the absence of a phosphate analog should be expressed by its 
ability to inhibit the binding of the analog. Data for this are presented 
in Figure 16B. This result shows that at two concentrations of 
Figure 16. The effect of the coenzyme structure on properties of the 
active site of phosphorylase a. 
A. Determination of the activity properties of apophosphory-
lase a. The assay mixture contained 1% [l^C]glycogen, 
10 I# ^ -glycerophosphate, 7.5 mM 2-mercaptoethanol, 
1 mg/ml apophosphorylase a (o) or 2.5 yg/ml phosphorylase 
a C*)> and the indicated amounts of at pH 6.8 and 
30° C. The reaction mixture was incubated for 10 
minutes and then terminated as described under 
EXPERIMENTAL PROCEDURES. The activity is expressed as 
counts per minute of reaction. 
B. The effect of the substrate on the Kj^ for phosphite 
and pyridoxal reconstituted phosphorylase a. Activity 
was assayed as described by Illingworth and Cori (103) 
in the presence of 1% glycogen, 10 mM $-glycerophosphate, 
7.5 mM 2-mercaptoethanol, 0.2 mg/ml pyridoxal 
phosphorylase a, 16 mM (•) or 37.5 mM (o) glucose-1-P, 
and the indicated amounts of sodium phosphite at pH 
6.8 and 30° C. 
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glucose-l-P, 16 mM and 37.5 mM, the for phosphite is unchanged while 
the maximal velocity is substantially increased. This suggests that 
glucose-l-P may be incapable of binding to the active site in the 
absence of the phosphoryl portion of the coenzyme. 
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DISCUSSION 
Rabbit skeletal muscle glycogen phosphorylase Jb, as initially 
purified, was found to require AMP for activity yet this nucleotide 
was not utilized during the catalytic process (32), thus presenting 
an early recognition of the allosteric control of this enzyme. Further 
allosteric controls on phosphorylase activity have subsequently been 
recognized. These include the phosphorylation of the enzyme to the ^  
form and the presence of a second nucleotide site where binding is 
inhibitory. In 1965, Monod ^  (57) provided a model for enzymatic 
allosteric transitions assuming an inactive T state and an active R 
state. The existence of these two conformations have been confirmed 
for the phosphorylase molecule by various methods, most notably through 
recent x-ray crystallographic studies which have delineated the sections 
of the molecule which undergo major conformational changes during the 
T ^  R transition (60). 
Kastenschmidt et al. (61) have reported an allosteric constant, 
L (L = T/R), for phosphorylase ^  in the absence of ligands of 6100 
at 29° C. This equilibrium constant corresponds to a AG for the T R 
transition of 5.2 kcal mol Helmereich et al. (62) have found that 
for phosphorylase a this same allosteric constant is between 3 and 13 
at 23° C. This corresponds to a AG of 0.6 to 1.5 kcal mol"^, thus 
phosphorylation results in a stabilization of the allosteric equilibrium 
by 3.7 to 4.6 kcal mol ^. Recent crystallographlc studies have shown 
that the serine phosphate of phosphorylase a Interacts with Arg 69 
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near the subunit interface (35). This interaction probably accounts 
for the stabilization of the allosteric equilibrium upon phosphorylation 
of the enzyme. 
Besides the ability of AMP and phosphorylation of the enzyme to 
shift the allosteric equilibrium in favor of the R state, recent x-ray 
crystallographic and kinetic evidence have shown that a second 
nucleotide site exists on phosphorylase where binding is competitive 
with the substrate, glucose-1-P, which binds 10 & away (53). Binding 
at this site stabilizes the T conformer. Of the compounds capable 
of inhibiting phosphorylase by binding to this site, the more 
hydrophobic compounds such as adenosine, caffeine, and riboflavin are 
more effective than the more hydrophilic nucleotides. 
Madsen and coworkers have suggested from kinetic studies using 
phosphorylase that there is an interaction between the nucleo­
side inhibitor sites on a dimer (53). Using phosphorylase the 
data presented here show that this apparent cooperativity is attributable 
to glucose-1-P binding, and replots exhibit linearity suggesting no 
significant interaction between inhibitor sites under these conditions. 
The kinetic plots of Madsen and coworkers are incapable of providing 
a distinction between cooperativity of inhibitor binding and increased 
cooperativity of substrate binding induced by the inhibitor (53). 
The effect of the inhibitor on glucose-l-P binding is that predicted 
by the model of Monod ^  al. (57). Since caffeine and glucose stabilize 
the T conformer, the cooperativity of glucose-l-P would be expected 
to Increase since the degree of cooperativity is dependent upon the 
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allosterlc constant. The linearity of the replots for these inhibitors 
may be due to the relative amounts of T and R conformers and need not 
imply that there is no interaction between subunits for the T conformer. 
Kasvinsky ^  (121) have shown a synergistic relationship between 
glucose binding and binding at the nucleoside inhibitor site. These 
authors calculated that the inhibition constant for caffeine and 
phosphorylase ^  decreased from 0.2 mM in the absence of glucose to 
0.06 mM in the presence of saturating glucose. This is probably due 
to the increased predominance of the T state in the presence of glucose. 
The effect of 1,2-dimethoxyethane on the binding parameters of 
caffeine and glucose is consistent with the ability of this solvent 
to facilitate the T -> R conversion. The larger effect of 10% (v/v) 
1,2-dlmethoxyethane on caffeine binding may be due to a direct solvent 
effect. The inclusion of an organic solvent increases the hydrophobicity 
of the medium, so that the affinity of a hydrophobic compound for an 
apolar site on the enzyme would be expected to decrease. The ability 
of organic solvents to "solvate" hydrophobic substrates or inhibitors 
from their binding site has been previously described for 
a-chjonotrypsin (122). 
Nucleotide activation of rabbit liver phosphorylase exhibits 
properties markedly different from the muscle isozyme. The liver enzyme 
is only slightly active in the presence of AMP. Further activation 
requires the presence of high salt concentrations (48,49,123) or high 
concentrations of glucose-1-P (123). These conditions are similar to 
those found necessary for best activation of skeletal muscle 
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phosphorylase ^  in the presence of IMP (109). The presence of the 
nucleoside inhibitor site on the liver isozyme has been reported by 
Kasvinsky et al. (121), although no information is available on the 
relative affinity of nucleotides for the two sites. 
The results presented here on nucleotide activation of liver 
phosphorylase _b in the presence of 1,2-dimethoxyethane suggest that, 
in contrast to the situation observed with skeletal muscle phosphorylase, 
AMP may have an affinity for the nucleoside inhibitor site which is 
comparable to or greater than its affinity for the activator site. Only 
after AMP inhibition at the inhibitor site is reduced by the solvent 
can activation by the nucleotide be seen. This suggestion is consistent 
with the report that the low activity with liver phosphorylase ^  is 
due to a high for glucose-1-P (123). 
These results also suggest that 1,2-dimethoxyethane may be useful 
in determining total phosphorylase levels in liver extracts. The 
current assay utilizing high levels of fluoride or sulfate (49) is 
inadequate since these anions inhibit liver phosphorylase a activity 
while giving only partial activation of phosphorylase h. In contrast, 
10% (v/v) 1,2-dimethoxyethane does not affect liver phosphorylase ^  
activity and activates liver phosphorylase ^  in the presence of AMP or 
IMP to a level comparable to that of the a form. These results suggest 
that 1,2-dimethoxyethane may be useful in more accurately determining 
activities for the different forms of liver phosphorylase utilizing the 
low glucose-l-P assay described under "EXPERIMENTAL PROCEDURES". 
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The usefulness of this assay has recently been verified by 
Chrisman and Exton for phosphatase inactivation of liver phosphorylase 
^ (16). While phosphorylase a activity decreased 85%, there was 
essentially no change in total phosphorylase activity when it was 
assayed as suggested here. These authors also utilized the low for 
AMP and skeletal muscle phosphorylase jb in the presence of 10% (v/v) 
1,2-dimethoxyethane in order to detect low levels of AMP (16). They 
reported that as little as 1 yM AMP caused a detectable increase in 
activity under these conditions. 
The effect of 1,2-dimethoxyethane on the different forms of 
skeletal muscle phosphorylase presents further evidence that this 
solvent activates by shifting the allosteric equilibrium. Phosphorylase 
^ in the presence of AMP already appears to be nearly fully activated. 
Phosphorylase ^  in the absence of AMP can be activated by the solvent 
to the same extent as that obtained with AMP. AMP has been reported to 
lower the for glucose-l-P and phosphorylase a (64) and this same 
effect is seen with 1,2-dimethoxyethane. 
The data presented here suggest that the activation properties 
of the solvent cannot be explained by a difference in the aggregation 
state of the enzyme. Inclusion of the solvent facilitates the AMP-
induced tetramerization of phosphorylase This is again probably due 
to the ability of the solvent to stabilize the R form since glucose-l-P 
which facilitates this transition in the presence of AMP (61), also 
increases the amount of tetramer in the presence of the nucleotide (109). 
Helmreich and coworkers have invoked an additional conformational state 
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for the tetramer in order to explain its allosteric properties (61). 
The lower activity of the tetramer and the difference in the solvent 
stimulation for this form are also consistent with this suggestion. 
The results obtained with 1,2-dimethoxyethane in the absence of 
nucleotides show that, in the presence of substrates, the allosteric 
equilibrium can be shifted to a large extent to the active form by 
this solvent alone. The activity obtained cannot be explained by 
contaminating AMP in the enzyme preparation or substrates since further 
increases in the solvent concentration result in an increased maximal 
velocity with little change in the K.^ for glucose-l-P. AMP activation 
is characterized by a change in the for substrates at limiting 
concentrations of this nucleotide (110). Further evidence that organic 
solvent activation is not attributable to endogenous nucleotides has 
been presented by Dreyfus et al. (124). These authors reported that 
butanedione modification of an essential arginine.residue eliminated 
the ability of phosphorylase ^  to be activated by AMP while there was 
no affect on t-butanol activation. Still further evidence for differences 
in solvent activation and that of AMP is provided by the differences in 
the acidic limb of the pH profiles. 
The effects of pH on glycogen phosphorylase activity obtained here 
suggest that pK^ exhibits a wide variance dependent upon the activity 
state of the enzyme. Kasvinsky and Meyer have reported that phosphorylase 
^ exhibits a pK^ at least one-half pH lower than that of phosphorylase 
_b in the presence of AMP (112). The results obtained here show that 
1,2-dimethoxyethane activation of phosphorylase ^  in the presence of 
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AMP correlates with a substantial lowering of the again suggesting 
the presence of a phosphorylase ^ -type molecules under these conditions. 
This change in the pH profile can be attributed to the catalytic 
reaction since the concentrations of effectors used here should be 
saturating according to the results of Kasvinsky and Meyer (112) 
utilizing and the consideration of the lower pKg for glucose-l-P 
which was utilized in these experiments. Phosphorylase ^  in the absence 
of activators and in the presence of 10% (v/v) 1,2-dimethoxyethane 
as the activator exhibits a pK^ which is approximately 0.2 units higher 
than that of AMP-activated phosphorylase 
Various authors have invoked an ionization of the phosphoryl 
portion of pyridoxal phosphate to explain the acidic limb of the pH 
profile (112,125). Although protonation of a carboxyl group could 
also be suggested to account for this ionization, it should be noted 
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that Feldmann and Hull using P NMR and phosphorylase ^  found that 
the presence of AMP and a substrate analog resulted in a deprotonation 
of the phosphoryl portion of pyridoxal phosphate (86). These authors 
further presented evidence that the resonance for phosphorylase ^  in 
the absence of effectors was insensitive to pH between 5.8 and 8.5. 
Addition of the activator AMPS and the substrate analog arsenate 
together, or arsenate alone resulted in a titration of the resonance 
below pH 6.4. These results, together with the x-ray crystallographic 
results which locate the coenzyme at the active site (74,77), makes it 
attractive to suggest that the acidic ionization is due to the 
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protonation of the phosphoryl portion of the coenzyme and that the 
formation of the dianion is an important step in the activation process. 
Using water-soluble carbodiimide modification, Ariki and Fukui 
have presented evidence for the presence of an essential residue with 
a pK between 5.0 and 5.5 (126). These authors further showed that 
inactivation was stimulated considerably by the addition of glucose-l-rP 
or P^. The modification was inhibited by a-glucosyl fluoride, which 
exhibits inhibition kinetics similar to those of glucose (127). These 
results suggest that this residue is modified when the enzyme is present 
in the R conformation. These authors presented evidence that addition 
of glycine ethyl ester in the presence of the carbodiimide resulted in 
its covalent attachment to the enzyme. Since glucosyl amine affected the 
modification in a manner similar to that of glycine ethyl ester while 
2-amino-2-deoxy glucose did not, these authors suggested that the 
modified residue was located near the Cl carbon of the sugar. These 
results suggest the presence of a phosphoryl or a carboxyl residue, with 
a pK similar to that seen in the activity pH profiles, near the point 
of catalysis. 
The results obtained on ionic strength activation of the acid 
hydrolysis of glucose-l-P suggests the importance of ions on this process 
while evidence supports an S^l mechanism under these conditions (72,114). 
From their work on ester hydrolysis, Bunton ^  (116) have presented 
evidence that this stimulation is attributable to the anion and that 
the rate enhancement is due to stabilization of the developing carbonium, 
both via an increase in the activity coefficient of the medium and 
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through specific interactions. Further, these authors found that 
the catalytic order of strong acids and salts suggested that the 
lower the charge density of the anion the more it stabilizes transition 
states with carbonium ion character (116). 
The effect of low charge density reagents is clearly seen in 
micellar catalysis (128). The ability of the cationic surfactant, 
hexadecy1trimethylammonium bromide, to catalyze unimolecular 
decarboxylations and dephosphorylations is greatest when a high charge 
density anion in the initial state is converted with a low charge 
density transition state. The anion in the transition state is 
stabilized by the low charge density cationic, trimethylammonium, 
head of the surfactant much more readily than the initial high 
charge density anion. 
The stimulation by anions and the further stimulation by a lower 
dielectric suggests that a similar situation may be important in the 
action of glycogen phosphorylase. The most likely candidates for such 
a function in phosphorylase would be the dianionic phosphoryl group of 
pyridoxal or a carboxylate anion. The increased inhibition by the 
transition state analog, 1,5-gluconolactone, in the presence of 
1,2-dimethoxyethane suggests that the transition state is stabilized 
under conditions where the maximal velocity is also increased. This 
oxonium intermediate can be considered to be a low charge density cation 
due to the delocalization of charge between the CI carbon and the ring 
oxygen. As mentioned previously, Feldmann and Hull (86) have shown that 
activation results in a deprotonation of the phosphoryl group of 
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pyridoxal phosphate. The results presented here also suggest the 
importance of the activity state of the enzyme on the pK^ of the pH 
profile. By analogy with the results on the acid hydrolysis of 
glucose-1-P, the activation process may be such as to allow the dianion 
of pyridoxal phosphate to stabilize the developing oxonium transition 
state. It should be noted however, that x-ray crystallographic studies 
on the T form of the enzyme also show the presence of two carboxyl 
groups near the catalytic site (35). The theoretical studies of 
Warshel and Levitt on lysozyme (129) suggest that electrostatic 
stabilization of the carbonium ion may be considerable. These authors 
have suggested that the presence of Asp 52 lowers the energy of the 
carbonium ion relative to the ground state by 9 kcal mol 
An involvement of the phosphoryl dianion as suggested here would 
allow for nucleophilic assistance by this group as well as electrostatic 
stabilization of the developing transition state. Such a mechanism 
would be considered to have both S„1 and S„2 characteristics, thus 
N N 
offering a possible explanation for the absence of a secondary isotope 
effect reported by Firsov et (130) under conditions where no 
covalent intermediate is found. 
Helmreich and coworkers have proposed a role for the phosphoryl 
portion of the coenzyme in the protonation of the bridge oxygen during 
the catalytic reaction (86,89). However, this suggestion conflicts with 
the results of Parrish ^  al. (76) which showed that fluorophosphate 
was similar to phosphite in its ability to activate pyridoxal 
reconstituted phosphorylase b. The difference in the ionization of 
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these two analogs (pK^ = 4.8 for fluorophosphate as compared to 
pKg <=6.2 for phosphite), suggests that fluorophosphate should not be 
as proficient in a protonation step during the reaction at the pH 
utilized in their experiments. 
The results reported here show that good preparations of 
apophosphorylase ^  can be made by using 1,2-dimethoxyethane in the 
resolution medium. The effect of this solvent on the resolution does 
not appear to be related to its effect on the allosteric equilibrium 
since both AMP and caffeine have been reported to inhibit the resolution 
of phosphorylase b (131). Good preparations of apophosphorylase a 
allow the effects of different pyridoxal phosphate analogs on the 
properties of phosphorylase £ to be determined. Yan et al. (90) have 
recently reported that the structure of the coenzyme is important for 
the regulation by glucose and caffeine of the dephosphorylation by 
phosphatase, and their regulations of the dimer-tetramer equilibrium. 
These authors have presented evidence for the importance of the dianionic 
form of the phosphoryl portion of the coenzyme in this regulation. 
The importance of the dianionic form in the expression of activity of 
the h form of the enzyme has been previously suggested by Parrish £t al. 
(76). 
The results presented here suggest that removal of the coenzyme 
results in flexibility for the serine phosphate when the linewldth 
for this residue is compared to that reported for the phosphoryl group 
of the coenzyme (86). Although no direct correlation can be made with 
the serine phosphate of the native enzyme due to the fact that the 
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31 P NMR resonances of the coenzyme and the serine phosphate coincide, 
various evidence suggests that the resonance seen for the apoenzyme has a 
narrower linewidth than that of the native enzyme. As is seen in Figure 
13B, addition of the pyridoxal portion of the coenzyme results in consid-
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erable linebroadening. Also, P NMR spectra obtained an apophosphorylase 
£ reconstituted with the phophonethyl aAalog of pyridoxal phosphate 
exhibit a broader linewidth for the serine phosphate than that exhibited 
here for the apoenzyme (R. J. Uhing, S. C. B. Yan, D. J. Graves, 
Department of Biochemistry and Biophysics, Iowa State University and 
P. Schmidt, Oklahoma City Medical Research Foundation, unpublished 
observations). The accessibility of the serine phosphate may account 
for the increased rate of dephosphorylation seen for the apoenzyme (90). 
The results obtained on the activity of the apoenzyme in the 
presence of increasing concentrations of inorganic phosphate suggest 
that the small amount of activity is due either to residual phosphorylase 
jE in the preparation or to an apoenzyme with a similar for substrates 
but which has a maximal velocity which is at least a thousand-fold 
lower than that seen for the native enzyme. No evidence can be seen 
for an enzyme form with a higher for the substrate. Parrish ^  al. 
(76) have reported that pyridoxal reconstituted phosphorylase ^  has 
a four-fold higher for glucose-l-P. Shimomura and Fukui have found 
that removal of the coenzyme from the a-glucan phosphorylase of potato 
tubers resulted in the loss of its ability to bind polysaccaride (132). 
, For these reasons it is suggested that the activity profile presented 
here represents residual native phosphorylase a activity rather than 
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any intrinsic activity of the apoenzyme. Furthermore, the results 
obtained with pyridoxal reconstituted phosphorylase a suggest that the 
presence of the phosphoryl portion of the coenzyme is necessary for the 
binding of substrates. 
Shimomura and Fukui have reported that pyridoxal phosphorylase ^  
has a structure similar to the native enzyme as determined by circular 
dichroism and ultraviolet absorption studies (98,99). Hybrid 
enzyme studies (97) have shown that the pyridoxal enzyme is capable 
of inducing activity in the immobilized native monomer, whereas the 
31 
apoenzyme is not. The results presented here on the P NMR of the 
serine phosphate also suggest that much of the native structure is 
retained in the pyridoxal enzyme, although conformational differences 
in the active site region must still be present since the data here 
suggests that the phosphoryl portion of the coenzyme is necessary for 
the binding of the substrate, glucose-l-P. 
The suggestion that a single group on the enzyme may be responsible 
for both the catalytic reaction and the binding of substrates is 
supported from other studies. Kasvinsky and Meyer have suggested, from 
a plot of pK^ versus pH, that the ionization of a residue with a pK 
of 5.1 is important in the binding of substrates by phosphorylase a (112). 
These authors have suggested that a group of the same pK^ is also 
important for the maximal velocity profile, from a plot of log 
V /K versus pH. 
max m 
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CONCLUSION 
Organic solvents are found to affect the allosteric equilibrium 
of glycogen phosphorylase. This is evidenced by changes in the 
activity properties of the enzyme. Inhibitors which stabilize the 
inactive T conformation of the enzyme, exhibit decreased affinities 
in the presence of the solvent, 1,2-dimethoxyethane. The caffeine 
is increased 6-fold in the presence of the solvent. Substrates and 
activators which bind to the active R conformation of the enzyme 
exhibit increased affinities in the presence of the solvent. This is 
most evident for the activator, AMP, which exhibits a 10-fold reduc­
tion for its in the presence of 1,2-dlmethoxyethane. The K^'s 
for the substrates, glucose-l-P and glycogen, is also reduced. 1,2-
Dimethoxyethane is also able to activate the enzyme in the absence of 
a nucleotide activator to a considerable extent. 
The allosteric activation of glycogen phosphorylase results in 
a change of the pK^ for the activity profile. The formation of the 
dianlonic form of the phosphoryl group of the coenzyme, pyrldoxal 
phosphate, may account for this change. By analogy to the effects 
of anions and a change in dielectric on the acid hydrolysis of 
glucose-l-P, it is suggested that the dianion of the coenzyme 
stabilizes the developing positive charge on the oxohlum intermediate. 
The use of 1,2-dlmethoxyethane allows for resolution of pyrldoxal 
phosphate from glycogen phosphorylase Results from NMR and 
kinetic studies suggest that the coenzyme also has a structural role 
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and that substrates may not bind in the absence of the phosphoryl 
portion of the coenzyme. 
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PART II. THE EFFECT OF DIETARY PYRIDOXINS ON GLYCOGEN 
ÎŒTABOLISM IN THE MOUSE 
93 
INTRODUCTION 
In 1954, Beaton and Goodwin reported that carbohydrate metabolism 
was altered in the vitamin Bg deficient rat (133). These alterations 
were evidenced by a reduction in blood glucose and a lowering of liver 
glycogen levels. Changes in blood glucose occurred within five days of 
vitamin depletion. In 1957, pyridoxal phosphate was found to be a 
prosthetic group of the glycogen degrading enzyme, glycogen phosphorylase 
(75). Subsequent studies have led to the suggestion that this enzyme 
functions as a reservoir for the vitamin (3). Glycogen phosphorylase 
activity in skeletal muscle is significantly reduced during pyridoxine 
deficiency (93,94). 
Although this enzyme is involved in a complicated regulatory 
scheme, the effects of its reduction during the vitamin deficiency on 
the other regulated enzymes concerned with glycogen metabolism have not 
been investigated to any extent. Furthermore, the effect of pyridoxine 
deficiency on glycogen metabolism in the liver has been largely ignored. 
This organ serves as the primary pool for carbohydrate storage in the 
body. It also appears to serve a major role in the metabolism of the 
various forms of vitamin B^ (134). Pyridoxine deficiency results in 
the preferential depletion of the vitamin in the cytosolic fraction of 
this organ (135), although the effect on specific metabolic processes 
is not understood. 
A role for vitamin B^ in diabetes mellitus has been suggested since 
treatment of various forms of the disease (e.g., gestational diabetes) 
with the vitamin improved the glucose tolerance curve but did not affect 
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plasma insulin levels (136). Adams e^. al. (137) have suggested that 
the improved glucose tolerance is due to the increased formation of a 
tryptophan metabolite, quinolinic acid, which is an inhibitor of hepatic 
phosphoenolpyruvate carboxykinase. 
The present study was initiated in order to investigate the effects 
of pyridoxine deficiency on carbohydrate metabolism in the mouse. The 
activity levels of several enzymes concerned with glycogen metabolism 
in both skeletal muscle and liver were determined. These included the 
enzymes responsible for its synthesis and degradation, glycogen synthase 
and glycogen phosphorylase, as well as the enzymes responsible for the 
interconversion between the various forms of these enzymes. The 
activity levels of these enzymes were determined in both the normal and 
diabetic state in order to investigate the effect of the pyridoxine 
nutritional state on this condition. 
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EXPERIMENTAL PROCEDURES 
Animals 
Three week old male mice from Biolab Corporation, St. Paul, 
Minnesota, were fed either a pyridoxine deficient diet (ICN Biochemicals, 
Cleveland, Ohio) or the same diet which had been supplemented with 3 ppm 
pyridoxine. The animals were allowed continuous access to water and 
food. The mice were maintained on the diet for seven weeks before 
being sacrificed. 
After five weeks on the diet, a portion of the group of mice had 
diabetes induced by intraperitoneal injections of streptozotocin (130 mg 
per kg of body weight). The diabetic condition was ascertained by 
elevated serum sugar levels. 
Preparation of Tissue 
Mice were sacrificed between 8 and 10 a.m. and portions of the 
hind leg skeletal muscle and of the liver were rapidly excised and 
homogenized in the cold in either 40 mM ^-glycerophosphate, 30 mM 
2-mercaptoethanol, 1 mM EDTA, and 100 mM sodium fluoride at pH 6.8 
(buffer A), or 50 mM imidazole, 30 mM 2-mercaptoethanol, and 3 mM EDTA 
at pH 7.5 (buffer B). The remaining tissue was frozen in dry ice-
acetone for later determination of glycogen content. Homogenates were 
centrifuged with a Beckman microfuge for 5 minutes at 4°C and the 
supernatant used for enzyme assays. 
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Enzymatic Assays 
Skeletal muscle glycogen phosphorylase was assayed utilizing the 
filter paper assay of Thomas e^ al. (104). The assay system contained 
1% glycogen, 16 mM glucose-l-P, 16 mM B-glycerophosphate, 12 mM 2-
mercaptoethanol, and 10 mM sodium fluoride at pH 6.8 and 30°C in the 
absence (phosphorylase ^  or presence (total phosphorylase) of 1 mM AMP. 
Liver glycogen phosphorylase was assayed according to the condi­
tions of Stalmans and Hers (49) using the filter paper assay of Thomas 
et al. (104). 
Skeletal muscle glycogen synthase activity was assayed in the 
presence of 10 mM UDPG, 1% glycogen, 50 mM Tris, 5 mM EDTA, 30 mM sodium 
fluoride, and either 14 mM sodium sulfate (synthase I) or 14 mM glucose-
6-P (synthase D + I) at pH 7.8 and 30°C utilizing the filter paper assay 
of Thomas et al. (104). 
Liver glycogen synthase activity was determined in a similar manner 
as the skeletal muscle isozyme with the exception that the concentration 
of glucose-6-P was 28 mM for the determination of glycogen synthase 
D + I. 
Phosphorylase kinase activity was assayed as described by Brostrom 
et al. (138) in the presence of 0.2 mM calcium. Activity was deter-
32 
mined by the incorporation of [ P]phosphate into skeletal muscle 
32 glycogen phosphorylase b from [y- P]ATP. 
Phosphorylase phosphatase activity was assayed as previously 
32 32 described (139) using [ P]phosphate release from [ P]phosphorylase 
Aspartate aminotransferase activity was assayed as described by 
Black e^ al. (91) at 23*C using 150 units of malate dehydrogenase. 
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The activity of cAMP-dependent protein kinase was determined as 
described by Reimann et al. (140) (Method B). The assay system con­
tained 22 mM MES, 1.8 mM theophylline, 22 mM sodium fluoride, 11 mM 
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magnesium acetate, 3.6 mg/ml casein, and 0.11 mM [y- P]ATP in the 
presence or absence of 11 yM cAMP at pH 6.9 and 30°C. 
The enzymatic reactions were initiated by the addition of the 
homogenation supernatant in buffer B for phosphorylase phosphatase and 
aspartate aminotransferase, and by the homogenation supernatant in 
buffer A for the remainder of the enzymes. All activity measurements 
were performed in duplicate and were linear with time. Activities are 
expressed in terms of milligrams of protein in the supernatant. 
Other Methods 
Protein was determined in the homogenation supernatants using the 
Bradford assay (141). Blood glucose was determined using glucose 
oxidase reagent ("Glucostat", Worthington Biochemical Corporation). 
Glycogen concentrations were determined by the phenol-sulfuric acid 
method (142). 
Statistical evaluation of the data was performed using ^ -test 
analysis. Differences with p values <0.10 are presented. Smaller 
differences are considered to be not significant (n.s.). Values for 
p^ are from comparisons with the nondiabetic mice maintained on the 
diet containing 3 ppm pyridoxine. Values for p^ are from comparisons 
of the deficient diabetic mice with the deficient nondiabetic mice. 
Data are presented as the mean ± the standard deviation. 
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Materials 
AMP, ATP, UDPG, glucose-1-P, g-glycerophosphate. Tris, MES, and 
theophylline were obtained from Sigma Chemical Company and used without 
further purification. Grade 1 imidazole from Sigma was used after three 
times recrystallization from reagent grade acetone. Shellfish glycogen 
from Sigma was further purified according to the method of Anderson and 
Graves (38). 2-Mercaptoethanol was obtained from Aldrich. [U-^^C] 
glucose-l-P and [U-^^C]UDFG were obtained from Amersham. [y-^^PjATP 
was prepared by the method of Glynn and Chappell (143). 
Rabbit skeletal muscle glycogen phosphorylase ^  was prepared 
according to the method of Fischer and Krebs (100). Skeletal muscle 
glycogen phosphorylase a was prepared by rabbit skeletal muscle phos-
32 phorylase kinase (101) using [y- P]ATP. Malate dehydrogenase was 
obtained from Sigma. 
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RESULTS 
Figure 1 depicts the growth rate of mice maintained on a diet con­
taining no or 3 ppm pyridoxine. Mice maintained in the absence of the 
vitamin exhibited a slower growth rate as well as an earlier growth 
plateau reached. Increasing the vitamin content to 30 ppm resulted in 
a slight enhancement of the growth rate over that seen at 3 ppm 
pyridoxine. McHenry (144) has reported that the lower body weight for 
Bg deficient rats is due to a decrease in body fat while the amount of 
protein in the deficient animal is similar to that of rats maintained on 
a diet which included the vitamin. 
The data included in this report are for mice which had been main­
tained for seven weeks on diets containing no or 3 ppm pyridoxine. 
After five weeks on the diet approximately one-half of the mice in each 
group was made diabetic by injection of streptozotocin. The deficient 
diabetic mice appeared to be healthier than their nondiabetic counter­
parts as evidenced by increased activity and appetite and a lower 
mortality rate. 
The effect of the diet and the diabetic condition on the levels of 
blood glucose and storage glycogen is summarized in Table I. and 
refer to the normal and diabetic mice maintained on the diet containing 
3 ppm pyridoxine. NQ and DQ refer similarly to the mice maintained on 
the diet lacking the vitamin. The values in parentheses refer to the 
number of mice in the determination. deficiency results in a 
significant (p^ < 0.001) reduction in the blood glucose level as has 
been previously reported by Beaton and Goodwin (133). This reduction 
Figure 1. The effect of dietary pyridoxine on the growth rate of mice. 
Mice were maintained on diets in the absence of 
pyridoxine (o) or in the presence of 3 ppm pyridoxine (•). 
At the indicated times the average weight was determined. 
The values in parentheses Indicate the number of mice in each 
group. 
Weight Average (gm) 
N3 W 
Table I. Blood glucose and storage glycogen levels 
«3 D3 Pi NQ Pi Dp Pi P2 
Blood glucose 160 ±20 410 ±120 <0.001 90 ±10 <0.001 370 ±70 <0.001 <0.001 
(mg %) (10) (8) (7) (11) 
Liver glycogen 29 ±12 14 ± 11 <0.05 40 ±37 n.s. 25 ±24 n.s. n.s. 
(yg/mg of tissue) (10) (7) (8) (11) 
Muscle glycogen 
(yg/mg of tissue) 1.59± 0.45 1.80± 0.31 n.s. 2.24± 0.78 <0.05 1,84± 0.91 n.s. n,s. 
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may be a result of an alteration in the hormonal control in the deficient 
animal since induction of the diabetic state results in an elevation of 
the blood glucose to levels similar to those seen for diabetic mice 
maintained on the supplemented diet. The lower blood sugar levels do 
not appear to be due to a reduction in storage glycogen in the deficient 
animal since, as is seen in Table I, these levels are similar to those 
of the animals which have been supplied with the vitamin. 
The liver glycogen levels exhibit a much larger variance for the 
deficient animal when compared to the supplemented animal. Whereas 
the levels were maintained within a narrow range for the supplemented 
animals in both the normal and diabetic state, those of the deficient 
mice varied between 1 and 120 pg per mg of tissue for the normal mice 
and between 2 and 65 yg per mg of tissue for the diabetic mice. In con­
trast to those of liver, muscle glycogen levels do not appear to be as 
significantly affected by the experimental conditions. Lyon and Porter 
(94) have previously reported that skeletal muscle glycogen levels do 
not change in deficiency. 
The effect of Bg deficiency on the activities of the glycogen 
metabolizing enzymes in skeletal muscle is summarized in Table II. The 
deficient condition results in a significant reduction in total phos-
phorylase levels as has been previously reported (93-95). Also similar 
to that reported previously (93), this reduction of total phosphorylase 
activity occurs while normal levels of the active form, phosphorylase a, 
are maintained. 
Table II. Glycogen metabolizing enzymes (muscle) 
^3 Pi *0 Pi »0 Pi P2 
Phosphorylase ^  
(pmole/min • mg) 
0 .54±0 
(10) 
.19 0 .49±0 
(8) 
.14 n.s. 0 .68± 0.18 
(8) 
n.s. 0 .55+0 
(11) 
.18 n.s. n.s. 
Total phosphorylase 
(umole/min • mg) 
2 .24+0 
(10) 
.33 2 .12±0 
(8) 
.24 n.s. 0 .99+ 0.24 
(8) 
<0.001 0 .89±0 
(11) 
.12 <0.001 n.s. 
Phosphorylase 
total 
0 .24+0 
(10) 
.08 0 .24±0 
(8) 
.09 n.s. 0 .69± 0.15 
(8) 
<0.001 0 .61+0 
(11) 
.16 <0.001 n.s. 
Synthase I 
(nmole/min • mg) 
25 .4 ±3 
(10) 
.4 24 .4 ±4 
(8) 
.0 n.s. 12 .3 ± 5.6 
(8) 
<0.001 9 .6 ±5 
(11) 
.2 <0.001 n.s. 
Synthase D + I 
(nmole/min • mg) 
48 .5 ±7 
(10) 
.8 54 .1 ±7 
(8) 
.2 n.s. 59 .6 ±22.9 
(8) 
n.s. 44 .0 ±4 
(11) 
.3 n.s. <0.05 
Synthase 
I/(D+I) 
0 .54+0 
(10) 
.11 0 .46±0 
(8) 
.08 <0.1 0 .21+ 0,06 
(8) 
<0.001 0 .22+0 
(11) 
.11 <0.001 n.s. 
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Although the levels of total glycogen synthase in muscle are 
similar in the supplemented and deficient mice, there is a signif­
icant (p^ < 0.001) reduction of the active I form of the enzyme in the 
deficient state. This condition apparently does not lead to mobilization 
of glycogen stores since, as is shown in Table I, the glycogen levels 
in Bg deficient mice are at least as large as those of the animals 
which had been supplemented with the vitamin. 
The data summarized in Table III show that although dramatic 
effects are seen for the activity ratios of glycogen phosphorylase and 
glycogen synthase (Table II), corresponding large significant increases 
in the activity ratios of phosphorylase kinase and cAMP-dependent 
protein kinase are not witnessed. The pH 6.8 and pH 8.2 activities of 
phosphorylase kinase decrease in both the normal and diabetic Bg 
deficient animals. Although there appear to be slight changes in the 
cAMP-dependent protein kinase activity under the different conditions, 
corresponding changes are not seen for phosphorylase kinase. Also seen 
in Table III is a slight increase in phosphorylase phosphatase activity 
for Bg deficient mice in both the normal and diabetic state. 
The data presented in Table IV show that in the deficient state 
liver glycogen phosphorylase exhibits a more pronounced reduction in 
activity than that seen for the muscle isozyme (Table II). In contrast 
to the situation exhibited by the muscle enzyme, this reduction is 
similar for phosphorylase a and total phosphorylase. The activity ratio 
for phosphorylase in the deficient state is similar to that obtained for 
the Bg supplemented animals. Phosphorylase in liver accounts for 
Table III. Interconverting enzymes (muscle) 
*3 O3 Pi ^0 Pi »0 Pi P2 
Phosphorylase kinase 
pH 6.8 (nmole/min • mg) 
1 .86±0 
(10) 
.32 1 .651 0 
(8) 
.35 n.s. 1. 401 0 
(8) 
.24 <0.01 1 .2310 
(11) 
.49 <0.01 n.s. 
Phosphorylase kinase 
pH 8.2 (nmole/min • mg) 
6 .9311 
(10) 
.75 6 .461 0 
(8) 
.94 n.s. 4. 651 1 
(8) 
.21 <0.01 4 .1711 
(11) 
.17 <0.001 n.s. 
Phosphorylase kinase 
pH 6.8/pH 8.2 
0 .2710 
(10) 
.05 0 .261 0 
(8) 
.07 n.s. 0. 311 0 
(8) 
.06 n.s. 0 .2910 
(11) 
.09 n.s. n.s. 
Phosphorylase phosphatase 
(nmole/min • mg) 
2 .1710 
(10) 
.63 2 .321 0 
(8) 
.41 n.s. 2. 701 0 
(8) 
.52 <0.10 2 .9610 
(11) 
.57 <0.01 n.s. 
Protein kinase 
-cAMP (pmole/min• mg) 
17 .7 17 
(10) 
.9 25 .7 113 
(8) 
.4 n.s. 31. 1 117 
(7) 
.8 <0.05 9 .3 14 
(11) 
.2 <0.01 <0.01 
Protein kinase 
+cAMP (pmole/min • mg) 
28 .6 17 
(10) 
.7 38 .4 111 
(8) 
.0 <0.05 36. 3 113 
(8) 
.5 n.s. 19 .0 17 
(11) 
.9 <0.05 <0.01 
Protein kinase 
—cAMP /+c AMP 
0 .6010 
(10) 
.16 0 .651 0 
(8) 
.28 n.s. 0. 781 0 
(7) 
.22 <0.10 0 .6410 
(11) 
.31 n.s. n.s. 
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approximately 10% of the pyridoxal phosphate in the organ compared to 
approximately 90% in skeletal muscle (135), The depletion of liver 
phosphorylase activity found here is much greater than that reported by 
Lyon and Porter (94) and suggests that the Bg nutritional effect on the 
liver isozyme is significant. The assay system employed by the above 
authors was the same used for the measurement of skeletal muscle 
glycogen phosphorylase activity and has been found to be inadequate for 
the determination of the activity of the liver Isozyme (49,123). 
The total activity of liver glycogen synthase is similar for mice 
maintained on the deficient and B^ supplemented diets. The percentage 
of the active I form of the enzyme exhibits a significant (p^ < 0.05) 
increase in the deficient animal. This significance is lost upon induc­
tion of the diabetic state. The results presented here suggest signif­
icant differences between muscle and liver in the deficient state which 
cannot be explained by the total content of the glycogen metabolizing 
enzymes. In skeletal muscle the relative level of the active form of 
phosphorylase is increased in the deficient state with a corresponding 
reduction in the level of glycogen synthase I. Similar changes are not 
observed in liver. In fact, while the percentage of phosphorylase a^ 
remains constant, there is a slight increase in the percentage of 
glycogen synthase I in the deficient state. 
As has been mentioned previously, the liver glycogen levels exhibit 
a large variability in the B^ deficient state. As is seen in Table IV, 
similar phenomena are observed for both the levels of glycogen synthase 
and glycogen phosphorylase. The variability of glycogen and its 
Table IV. Glycogen metabolizing enzymes (liver) 
N3 Pi NQ ^1 ^3 ^1 ^2 
Phosphorylase a 236 ±30 285 ±36 <0.01 49 ±34 <0.001 49 ±34 <0.001 n.s. 
(nmole/min • mg) (10) (8) (8) (11) 
Total phosphorylase 205 ±31 239 ±32 <0.05 42 ±28 <0.001 42 ±26 <0.001 n.s. 
(nmole/min • mg) (10) (8) (8) (11) 
Phosphorylase 1.15± 0.05 1.20± 0.07 n.s. 1.18± 0.05 n.s. 1.15± 0.11 n.s. n.s, 
a/total (10) (8) (8) (11) 
Synthase I 2.0 ± 1.1 1.5 ± 0.6 n.s. 3.0 ± 1.9 n.s. 2,1 ± 1.7 n.s. n.s, 
(nmole/min • mg) (10) (8) (8) (11) 
Synthase D + I 36.2 ± 7.2 41.3 ± 3.6 <0.10 33.2 ±21.0 n.s. 33.6 ±25.2 n.s. n.s. 
(nmole/min • mg) (10) (8) (8) (11) 
Synthase 0.05± 0.02 0.04± 0.01 n.s. 0.10± 0.06 <0.05 0.07± 0.03 n.s. n.s. 
I/(D+I) (10) (8) (8) (11) 
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metabolizing enzymes appear to be interrelated since, as is shown in 
Figures 2 and 3, the levels of these enzymes exhibit linear relationships 
with the amount of glycogen present for the individual mice. Linear 
regression analysis yields similar slopes for the two lines, 0.69 for 
glycogen synthase. This suggests that the variability of glycogen con­
tent is not due to relative differences in the levels of these enzymes. 
Although total enzyme activity levels are plotted here, similar profiles 
are obtained when the data are presented as the activities of the active 
form versus glycogen concentrations. 
The data presented in Table V suggest that the levels of the inter-
converting enzymes in liver are increased in the vitamin deficiency. 
Although no significant difference is seen for the activity ratio of 
phosphorylase kinase, there is a substantial increase in the activity 
ratio of cAMP-dependent protein kinase. There is also an increase in 
the activity of phosphorylase phosphatase. A similar larger relative 
increase in glycogen synthase phosphatase activity as compared to cAMP-
dependent protein kinase activity could explain why there is an increase 
in the relative amount of glycogen synthase I in the deficient state. 
In the deficient diabetic state, there is a still further increase in 
the activity of the protein kinase. Correspondingly, the relative 
amount of glycogen synthase I is no longer significantly different from 
the Bg supplemented animal. 
The data on another containing enzyme, aspartate aminotrans­
ferase (Table VI), suggest that the decreases observed for glycogen 
phosphorylase under these experimental conditions are not specific. 
Figure 2. The interrelationship between total glycogen synthase activity 
and liver glycogen content in the deficient mouse. 
The data are presented for the determinations from each 
mouse. The data are for both the deficient nondiabetic (•) 
and the deficient diabetic (o) mice. 
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Figure 3. The interrelationshp between total glycogen phosphorylase 
activity and liver glycogen content in the deficient 
mouse. 
The data are presented for the determinations from each 
mouse. The data are for both the deficient nondiabetic (•) 
and the deficient diabetic (o) mouse. 
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Table V. Interconverting enzymes (liver) 
"3 "3 Pi "0 Pi ^0 Pi P2 
Phosphorylase kinase 0.14± 0.04 0.13± 0.02 n.s. 0.20+ 0.06 <0.05 0.19± 0.08 <0.10 n.s. 
pH 6.8 (nmole/min • mg) (10) (8) (8) (11) 
Phosphorylase kinase 0.15± 0.05 0.13± 0.02 n.s. 0.21± 0.06 <0.10 0.20± 0.09 n.s. n.s. 
pH 8.2 (nmole/min • mg) (10) (8) (8) (11) 
Phosphorylase kinase 0.92± 0.13 0.96± 0.08 n.s. 0.95± 0.03 n.s. 0.98± 0.06 <n.s. n.s. 
pH 6.8/pH 8.2 (10) (8) (8) (11) 
Phosphorylase phosphatase 0.25± 0.13 0.48± 0.33 <0.05 0.59+ 0.14 <0.001 0.65± 0.21 <0.001 n.s. 
(nmole/min • mg) (10) (8) (8) (11) 
Protein kinase 38 +35 30 ±19 n.s. 98 ±56 <0.05 105 ±32 <0.001 n.s. 
-cAMP (pmole/min • mg) (10) (8) (8) (11) 
Protein kinase 63 ±38 50 ±12 n.s. 130 ±43 <0.01 106 ±33 <0.05 n.s. 
+cAMP (pmole/min • mg) (10) (8) (8) (11) 
Protein kinase 0.45± 0.27 0.57± 0.27 n.s. 0.82± 0.13 <0.01 1.00+ 0.13 <0.001 <0.01 
-cAMP/H-cAMP (10) (8) (8) (11) 
Table VI. Aspartate aminotransferase activity 
N, N, 
Muscle aspartate aminotransferase 0.28+0.08 0.32±0.08 n.s. 0.14±0.05 <0.001 0.14±0.04 <0.001 n.s. 
(AA^^g/min mg) (10) (8) (8) (11) 
Liver aspartate aminotransferase 0.16+0.06 0.22±0.06 <0.05 0.07±0.07 <0.01 0.05±0.04 <0.001 n.s, 
(AA^^g/min mg) (10) (8) (8) (11) 
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The relative decreases seen for skeletal muscle and liver aspartate 
aminotransferases are similar to those observed for glycogen phos-
phorylase. Various aminotransferases are important in the maintenance 
of carbohydrate levels by providing gluconeogenic precursors from amino 
acids. It is thus conceivable that alterations of carbohydrate 
metabolism under various conditions could be due to changes in the 
activities of these enzymes. 
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DISCUSSION 
In 1964, Krebs and Fischer (3) proposed that skeletal muscle 
glycogen phosporylase serves as a reservoir for vitamin based on the 
substantial amount of the body's content of this vitamin which is con­
tained in the enzyme. Since then, various studies have been reported 
which seem to support this hypothesis. Phosphorylase activity per gram 
of muscle or per milligram of protein is significantly reduced in 
deficiency and this reduction is reversed by resupplementation with the 
vitamin (93-95). Black e^ al. (91) have reported that rats fed high 
levels of pyridoxine exhibited increases in skeletal muscle glycogen 
phosphorylase activity in a constant ratio with the increased B^ content 
of the tissue. Smaller increases, which plateaued within two weeks, 
were observed for two other B^ containing enzymes, alanine and aspartate 
aminotransferases. A recent study (95) has shown that a further condi­
tion is necessary for the depletion of skeletal muscle glycogen phos­
phorylase. This condition is the starvation which results from the 
anorexia associated with B^ deficiency. These authors further reported 
that starvation also resulted in reductions of skeletal muscle phos­
phorylase for rats which had been supplemented with B^. Smaller changes 
were observed for aspartate aminotransferase while no significant reduc­
tion was observed for alanine aminotransferase. 
Black e^ al. (95) have reported that aspartate aminotransferase 
decreases to the same extent as that observed for glycogen phosphorylase 
during B^ deficiency. A similar observation was made here for skeletal 
muscle. This effect appears to be specific for B^ containing enzymes, 
118 
since other enzymes concerned with glycogen metabolism do not exhibit 
corresponding decreases in activity. 
The results on liver show that glycogen phosphorylase in this organ 
exhibits a larger relative decrease in activity during the deficient 
state when compared to the same enzyme in skeletal muscle. Again there 
was a corresponding decrease in the activity of another containing 
enzyme, aspartate aminotransferase. Muscle glycogen phosphorylase was 
approximately 55% lower than the control after seven weeks on the 
deficient diet, whereas liver phosphorylase activity was approximately 
80% below the control. Other enzymes associated with glycogen metabolism 
in the liver are not depleted in the deficiency state. 
Skeletal muscle glycogen phosphorylase meets criteria for being a 
reservoir in that its concentration increases when the vitamin is present 
in surplus amounts, a large proportion of the body's content of vitamin 
is contained in this single enzyme, and deficiency leads to release 
of the vitamin from this enzyme (3,91,93-95). The results in this 
report show, however, that deficiency also leads to a decrease in the 
activity of liver glycogen phosphorylase and both liver and skeletal 
muscle aspartate aminotransferases. The relative decrease in activity 
for these enzymes is at least as great as that seen for skeletal muscle 
glycogen phosphorylase. The effect of these losses on the maintenance 
of the vitamin pool would not be expected to be as great as the effect 
of skeletal muscle glycogen phosphorylase depletion because of the 
smaller relative amounts of these enzymes. 
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The results obtained here support the studies by McHenry and co­
workers (133,144) suggesting that deficiency results in alterations 
of carbohydrate matabolism. These alterations are manifested by a 
reduction in blood sugar and a large variability in the liver glycogen 
content. The reduced blood sugar levels do not appear to be a result 
of a starvation condition since all the deficient animals had lower '< 
blood sugar levels independent of whether liver glycogen levels were 
below normal or well above it. Furthermore, induction of the diabetic 
state in these animals resulted in the elevation of blood sugar to levels 
similar to those of mice which had been supplemented with the vitamin. 
The change in blood sugar levels in the deficient state may be due to 
changes in the amounts of circulating hormones. If such changes do 
exist they are not manifested by changes in the activity ratios of 
either liver glycogen phosphorylase or liver glycogen synthase. Further­
more, Lyon and Porter (94) have reported that deficiency does not 
produce changes in glucose-6-phosphatase activity in liver. 
The variability of liver glycogen concentrations does not appear 
to be due to alterations in the activities of glycogen phosphorylase or 
glycogen synthase. The activity ratios of these enzymes do not exhibit 
changes correlating with the concentrations of glycogen. The activity 
levels of the interconverting enzymes do not decrease during the 
deficiency state, instead they all exhibit significant increases. The 
levels of these enzymes do not appear to correlate with the levels of 
liver glycogen synthase activities with glycogen concentration under 
conditions where the levels of other enzymes involved with glycogen 
120 
metabolism do not exhibit corresponding variabilities, suggesting that 
this phenomenon may be due to the greater affinity of these metabolizing 
enzymes for the polysaccaride. 
A similar condition does not appear to exist in skeletal muscle. 
There appears to be no corresponding changes between the levels of the 
glycogen metabolizing enzymes and the levels of glycogen for the 
individual animals. Furthermore, it has been reported that during 
surplus Bg supplementation, where skeletal muscle glycogen phosphorylase 
increases more than five-fold, no corresponding increase for tissue 
glycogen is observed (145). 
Bosron e^ al. (135) have reported that B^ deficiency results in 
preferential depletion of the cytosolic fraction of pyridoxal phosphate 
in the liver. Furthermore, these authors reported that glycogen phos­
phorylase accounts for 10% of the pyridoxal phosphate in this tissue 
and aspartate aminotransferase accounts for an additional 4 to 7%. 
The results presented here show that these enzymes exhibit large 
decreases in activity in the deficient state. These enzymes could 
account for a significant portion of the loss of the cytosolic pool of 
the vitamin during deficiency. 
Illingworth e^ al. (93) have suggested that the lack of a change 
in phosphorylase ^  activity in skeletal muscle in the deficient state, 
where total phosphorylase activity was significantly reduced, may be a 
mechanism to maintain normal glycogen metabolism. If this were the 
cause, one would not expect to find a concommitant decrease in the 
percent I of glycogen synthase. This observation suggests that the 
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actual cause is probably more complex. The increase in phosphorylase 
^ and decrease in synthase I may represent a change in the metabolic 
state of the tissue. The phosphorylation states of these enzymes are 
dependent not only on the relative activities of the kinases and phos­
phatases but also on the levels of various metabolites. The activity 
states of these enzymes would suggest that skeletal muscle would be more 
actively degrading glycogen, although glycogen levels in the 
deficient animals are not lower than normal. 
Diabetes mellitus is evidenced by significant alterations in carbo­
hydrate metabolism. A role for in this condition has been suggested 
since.treatment of various forms of this disease (e.g., gestational 
diabetes) with the vitamin improved the glucose tolerance curve but did 
not affect plasma insulin levels (137). It was of interest, therefore, 
to investigate the effect of the diabetic condition on the enzyme levels 
of glycogen metabolism in the normal and B^ deficient state. The 
results presented here show that neither of the containing enzymes 
examined in this study were significantly altered during the two week 
diabetic period. Also, the effects of the diabetic condition appeared 
to be similar in the normal and deficient mouse, even though phos­
phorylase levels were significantly reduced in the latter. 
In summary, the effect of vitamin B^ deficiency on enzymes involved 
in glycogen metabolism is evidenced primarily by a decrease in the levels 
of glycogen phosphorylase. The condition results in a change in the 
activity ratios of the glycogen metabolizing enzymes in skeletal muscle 
but not in liver. The levels of the interconverting enzymes exhibit 
122 
changes in both kinase and phosphatase activity. The results presented 
here support the concept of McHenry (144) that carbohydrate metabolism is 
altered as a result of vitamin deficiency. 
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CONCLUSION 
Bg deficiency results in alterations in glycogen metabolism in 
the mouse. These alterations are evidenced by a reduction in blood 
glucose and a large variability for the liver glycogen stores. Induc­
tion of the diabetic state in these animals results in an elevation of 
blood sugar levels to values similar to those seen for Bg mice which 
had been supplemented with the vitamin. 
Bg deficiency results in preferential depletion of enzymes which 
contain the vitamin. Other enzymes associated with glycogen metabolism 
do not exhibit large decreases in activity. In fact, the intercon-
verting enzymes in liver exhibit significant increases in activity in 
the deficient state. Important differences exist between skeletal 
muscle and liver in terms of the effect of Bg deficiency on glycogen 
metabolism. Skeletal muscle exhibits an increase in the activity 
ratio of glycogen phosphorylase and a decrease in the activity ratio 
of glycogen synthase, suggesting an altered metabolic state. Liver 
does not exhibit similar changes, but shows a variance in the activi­
ties of these enzymes for the individual mice which correlates with 
the variability of glycogen content. The results also show that Bg 
deficiency results in a larger decrease in activity for liver enzymes 
than for those of skeletal muscle. 
124 
ACKNOWLEDGEMENT S 
Thanks are extended to the following people for performing assays 
during this experimentation; Drs. Sau Chi Betty Yan, Mikihiko 
Kobayashi, and Joyce Miller, as well as Bill Harris, Mike Hurst, 
Lee Graves, Chang Yem Chumg, and Jesse Chan. Thanks are also extended 
to Terry Brooks for care of the animals. 
125 
LITERATURE CITED 
1. Hanes, C. S. and Maskell, E. J. (1942), Biochèm. J. 36, 76. 
2. Lamer, J., Villar-Palasi, C. and Rechman, D. J. (I960), Arch -
Biochem. Biophys. 86, 56. 
3. Krebs, E. G. and Fischer, E. H. (1964), Vltam. Horm. 22, 399. 
4. Cori, C. F. and Illingworth, B. (1956), Proc. Natl. Acad. Sci. USA 
547. 
5. Cori, G. T. and Green, A. A. (1943), J. Biol. Chem. 151, 31. 
6. Madsen, N. B. and Cori, C. F. (1955), Biochim. Biophys. Acta 
18, 156. 
7. Titani, K., Koide, A., Hermann, J., Ericsson, L. H., Kumar, S., 
Wade, R. D., Walsh, K. A., Neurath, H. and Fischer, E. H. (1977), 
Proc. Natl. Acad. Sci. USA 74, 4762. 
8. Titani, K., Cohen, P., Walsh, K. A. and Neurath, H. (1975), 
FEBS Lett. 120. 
9. Green, A. A. and Cori, G. T. (1943), J. Biol. Chem. 151, 21. 
10. Madsen, N. B. and Cori, C. F. (1956), J. Biol. Chem. 223, 1055. 
11. Graves, D. J. and Wang, J. H. (1972), in The Enzymes, ed. P. D. 
Boyer, 3rd ed.. Academic Press: New York, 1_, 435. 
12. Huang, C. Y. and Graves, D. J. (1970), Biochemistry 9. 660. 
13. Assaf, S. A. and Graves, D. J. (1969), J. Biol. Chem. 244, 554. 
14. Appleman, M. M., Krebs, E. G. and Fischer, E. H. (1966), 
Biochemistry 5, 2101. 
15. Walsh, D. A., Perkins, J. P. and Krebs, E. G. (1968), J. Biol. 
Chem. 243, 3763. 
16. Chrisman, T. D. and Exton, J. H. (1980), J. Biol. Chem. 255, 3270. 
17. Walsh, D. A., Perkins, J. P., Brastrom, C. 0., Ho, E. S. and 
Krebs, E. G. (1971), J. Biol. Chem. 246. 1968. 
126 
18. Krebs, E. G. and Beavo, J. A. (1979), Ann. Rev. Blochem. 48, 923. 
19. van der Werve, G., Stalmans, W. and Hers, H. G. (1977), Blochem. J. 
162, 143. 
20. Witters, L. A. and Avruch, J. (1978), Biochemistry 17, 406. 
21. Brandt, H. Lee, E. Y. C. and Killllea, S. D. (1975), Blochem. 
Biophys. Res. Commun. 63, 950. 
22. Huang, F. L. and Gllnsmann, W. H. (1975), Proc. Natl. Acad. Sci. 
USA 22, 3004. 
23. Huang, F. L. and Gllnsmann, W. H. (1975), FEBS Lett. 62, 326. 
24. Huang, F. L. and Gllnsmann, W. H. (1976), Eur. J. Blochem. 70, 419. 
25. Tao, S. H., Huang, F. L., Lynch, A. and Gllnsmann, W. H. (1978), 
Blochem. J. 176, 347. 
26. Nichols, W. K. and Goldberg, N. D. (1972), Biochim. Biophys. Acta 
279, 1972. 
27. Carlson, G. M., Bechtel, P. J. and Graves, D. J. (1979), Advances 
in EnzymoloRy 50, 41. 
28. Nolan, C., Novoa, W. B., Krebs, E. G. and Fischer, E. H. (1964), 
Biochemistry 3, 542. 
29. Martensen, T. M., Brotherton, J. E. and Graves, D. J. (1973), 
J. Biol. Chem. 248, 8329. 
30. Bailey, J. M. and Whelan, W. J. (1972), Blochem. Biophys. Res. 
Commun. 46, 191. 
31. Bot, G. and Dosa, I. (1971), Acta Biochim. Biophys. Acad. Sci. 
Hung. 73. 
32. Cori. G. T., Colowick, S. P. and Cori, C. F. (1938), J. Biol. Chem. 
123. 381. 
33. Rahim, Z. H. A., Perrett, D., Lutaya, G. and Griffiths, J. R. 
(1980), Blochem. J. 186, 331. 
34. Fletterlck, R. J., Sygusch, J., Semple, H. and Madsen, N. B. (1976), 
J. Biol. Chem. 251. 6142. 
127 
35. Fletterick, R. J. and Madsen, N. B. (1980), Ann. Rev. Biochem. 
49, 31. 
36. Mott, D. M. and Bieber, A. L. (1968), Biochem.. Biophys. Rés. 
Commun. 30, 363. 
37. Anderson, R. A., Parrish, R. F. and Graves, D. J. (.1973), 
"Biochemistry 12, 1901. 
38. Anderson, R. A. and Graves, D. J. (1973), Biochemistry 12, 1895. 
39. Fletterick, R. J., Sprang, S. and Madsen, N. B. (1979), Can. 
J. Biochem. 57, 789. 
40. Shimomura, S. and Fukui, T. (1976), Biochemistry 15, 4438. 
41. Vanderbunder, M., Morange, M. and Bue, H. (1976), Proc. Natl. 
Acad. Sel. USA 73, 2696. 
42. Lee, Y. P. (1960), Biochim. Biophys. Acta 43, 25. 
43. Chen, G. S. and Segel, I. H. (1968), Arch. Biochem. Biophys. 
127, 164. 
44. Lerch, K. and Fischer, E. H. (1975), Biochemistry 14, 2009. 
45. Yunis, A. A. and Assaf, S. A. (1970), Biochemistry 9, 4381. 
46. Villar-Palasi, C. and Gazques-Martinex, I. (1968), Biochim. 
Biophys. Acta 159, 479. 
47. Yunis, A. A. and Arimura, G. K. (1968), Biochem. Biophys. Res. 
Commun. 33, 119. 
48. Wolf, D. P., Fischer, E. H, and Krebsj E. G. (1970), Biochemistry 
_9, 1923. 
49. Stalmans, W. and Hers, H. G. (1975), Eur. J. Biochem. 54, 341. 
50. Vereb, G. and Bot, G. (1979), Int. J. Biochem. 10, 697. 
51. Rahim, Z. H. A., Perrett, D. and Griffiths, J. R. (1976), 
FEBS Lett. 203. 
52. Wang, J. H., Kwok, S.-C., Wirch, E. and Suzuki, I. (1970), 
Biochem. Biophys. Res. Commun. 40, 1340. 
53. Kasvinsky, P. J., Madsen, N. B., Sygusch, J. and Fletterick, R. J. 
(1978), J. Biol. Chem. 253, 3343. 
128 
54. Soman, G. and Philip, G. (1975), Biochem. J. 147, 369. 
55. Kihlman, B. and Overgaard-Hansen, K. (1955), Exp. Cell Res, 
8, 252. 
56. Sprang, S. and Fletterick, R. J. (1979), J. Mol. Biol. 131, 523. 
57. Monod, J., Wyman, J. and Changeux, J. P. (1965), J. Mol. Biol. 
_12, 88. 
58. Johnson, L. N., Madsen, N. B., Mosley, J. and Wilson, K. S. (1974), 
J. Mol. Biol. 90^, 703. 
59. Fletterick, R. J., Sygusch, J., Madsen, N. B. and Johnson, L. N. 
(1976), J. Mol. Biol. 103, 1. 
60. Madsen, N. B., Kasvinsky, P. J. and Fletterick, R. J. (1978), 
J. Biol. Chem. 253, 9097. 
61. Kastenschmidt, L. L., Kastenschmidt, J. and Helmreich, E. (1968), 
Biochemistry ]_, 4543. 
62. Helmreich, E., Michaelides, M. C., and Cori, C. F. (1967), 
Biochemistry 6, 3695. 
63. Wang, J. H. and Black, W. J. (1968), J. Biol. Chem. 243, 4641. 
64. Engers, H. D., Shechosky, S. and Madsen, N. B. (1970), Can. 
J. Biochem. 48, 746. 
65. Engers, H. D., Bridger, W. A. and Madsen, N. B. (1970), Can. J. 
Biochem. 48, 756. 
66. Engers, H. D., Bridger, W. A. and Madsen, N. B. (1969), J. Biol. 
Chem. 244. 5936. 
67. Maddaiah, V. T. and Madsen, N. B. (1966), J. Biol. Chem. 241, 3873. 
68. Chao, J., Johnson, G. F. and Graves, D. J. (1969), Biochemistry 
8, 1459. 
69. Doudoroff, M., Barker, H. A. and Hassis, W. Z. (1947), J. Biol. 
Chem. 170, 147. 
70. Silverstein, R., Voet, J., Reed, D. and Abeles, R. H. (1967), 
J. Biol. Chem. 242, 1338. 
129 
71. Voet, J. G. and Abeles, R. H. (1970), J. Biol. Chem. 245, 1020. 
72. Tu, J.-I., Jacobson, G. R. and Graves, D. J. (.1971), Biochemistry 
20, 1229. 
73. Gold, A. M., Legrand, E. and Sanchez, G. (1971), J. Biol. Chem. 
246, 5700. 
74. Weber, I. T., Johnson, L. N., Wilson, K. S., Yeates, D. G., Wild, 
D. L. and Jenkins, J. A. (1978), Nature 274, 433. 
75. Baranowski, T., Illingworth, B., Brown, D. H. and Cori, C. F. 
(1957), Biochim. Biophys. Acta 25, 16. 
76. Parrish, R. F., Uhing, R. J. and Graves, D. J. (1977), Biochemistry 
_16, 4824. 
77. Sygusch, J., Madsen, N. B., Kasvinsky, P. J. and Fletterick, R. J. 
(1977), Proc. Natl. Acad. Sci. USA 74, 4757. 
78. Hedrick, J. L., Shaltiel, S. and Fischer, E. H. (1966), Biochemistry 
5, 2117. 
79. Shaltiel, S., Hedrick, J. L., Pocker, A. and Fischer, E. H. (1969), 
Biochemistry 8^, 5189. 
80. Pocker, A. and Fischer, E. H. (1969), Biochemistry 8, 5181. 
81. Vidgoff, J. M., Pocker, A., Hullar, T. L. and Fischer, E. H. (1974), 
Biochem. Biophys. Res. Commun. 57, 1166. 
82. Graves, D. J., Parrish, R. F., Uhing, R. J. and Korytnyk, W. (1977), 
llth Meeting Federation European Biochemical Societies in 
Copenhagen, Symposium (Al) on Regulatory Mechanisms of Carbohydrate 
Metabolism, ed. V. Esmann, Pergamon Press: Oxford, 42, 195. 
83. Kent, A. B., Krebs, E. G. and Fischer, E. H. (1958), J. Biol. Chem. 
232, 549. 
84. Pfeuffer, T., Ehrlich, J. and Helmreich, E. (1972), Biochemistry 
n, 2125. 
85. Pfeuffer, T., Ehrlich, J. and Helmreich, E. (1972), Biochemistry 
_11, 2136. 
86. Feldmann, K. and Hull, W. E. (1977), Proc. Natl. Acad. Sci. USA 
74, 856. 
130 
87. Palm, D., Schachtele, K., Feldmann, K. and Helmreich, E. J. M. 
(1979), FEES Lett. 101, 4031. 
88. Klein, H. W. and Helmreich, E. J. M. (1979). FEES Lett. 108. 209. 
89. Helmreich, E. J. M. and Klein, H. W. (1980), Angewandte Chémie, 
International Edition, (in press). 
90. Yan, S. C. B., Uhing, R. J., Parrish, R. F., Metzler, D. E., 
and Graves, D. J. (1979), J. Biol. Chem. 254. 8263. 
91. Black, A. L., Guirard, B. M. and Snell, E. E. (1977), J. Nutr. 
107, 1962. 
92. Fischer, E. H., Heilmeyer, L. M. G., Jr. and Haschke, R. H. (1971), 
Curr. Top. Cell. Reg. ^ ,211. 
93. Illingworth, B., Kornfeld, R. and Brown, D. H. (1960), Biochim. 
Biophys. Acta 42, 486. 
94. Lyon, J. B., Jr. and Porter, J. (1962), Biochim. Biophys. Acta 
248. 
95. Black, A. L., Guirard, B. M. and Snell, E. E. (1978), J. Nutr. 
108. 670. 
96. Withers, S. G., Sykes, B. D., Madsen, N. B. and Kasvinsky, P. J. 
(1979), Biochemistry 18. 5342. 
97. Feldmann, K., Zeisel, H. and Helmreich, E. J. M. (1976), Eur. 
J. Biochem. 6 5 ,  2 8 5 .  
9 8 .  Shimomura, S. and Fukui, T. (1977), J. Blochem. 81, 1781. 
99. Shimomura, S. and Fukui, T. (1978), Biochemistry 17, 5359. 
100. Fischer, E. H. and Krebs, E. G. (1962), Methods Enzymol. 369. 
101. Krebs, E. G. (1966), Methods Enzymol. 8^, 543. 
102. Shaltiel, S., Hedrick, J. L. and Fischer, E. H. (1966), Biochemistry 
5, 2108. 
103. Illingworth, B. and Cori. G. T. (1953), Biochem. Prep. 2» 1. 
104. Thomas, J. A., Schlender, K. K. and Larner, J. (1968), Anal. 
Biochem. 25, 486. 
131 
105. Kastenschmidt, L. L., Kastenschmidt, J. and Helmrexch, E. (1968), 
Biochemistry, ]_, 3590. 
106. Alberty, R. A. and Massey, V. (1954), Biochim. Biôphyà. Acta 
13, 347. 
107. Hill, A. V. (1910), J. Physiol. (London) W, iv. 
108. Janski, A. M., Natl. Insts. Health, personal communication. 
109. Black, W. J. and Wang, J. H. (1968), J. Biol. Chem. 243, 5892. 
110. Helmreich, E. and Cori, C. F. (1964), Proc. Natl. Acad. Sci. USA 
51, 131. 
111. Dreyfus, M., Vanderbunder, B. and Bue, H. (1978), FEBS Lett. 
95, 185. 
112. Kasvinsky, P. J. and Meyer W. L. (1977), Arch. Biochem. Biophys. 
181, 616. 
113. Hollo, J., Laszlo, E. and Hoschke, A. (1966), Staerke 18, 337. 
114. Bunton, C. A., Llewellyn, D. R., Oldham, K. G. and Vernon, C. A. 
(1958), J. Chem. Soc. 3588. 
115. Bunton, C. A. and Humeres, E. (1968), J. Org. Chem. 34, 572. 
116. Bunton, C. A., Crabtree, J. H. and Robinson, L. (1968), J. Amer. 
Chem. Soc. 90, 1258. 
117. Shaltiel, S. and Cortijo, M. (1970), Biochem. Biophys. Res. Commun. 
41, 594. 
118. Hoerl, M., Feldmann, K., Schnackerz, K. S. and Helmreich, E. J. M. 
(1979), Biochemistry 18, 2457. 
119. Graves, D. J., Carlson, G. M., Skuster, J. R., Parrish, R. F., 
Carty, T. J. and Tessmer, G. W. (1975), J. Biol. Chem. 250, 2254. 
120. Honikel, K. G. and Madsen, N. B. (1973), Can. J. Biochem. 51, 344. 
121. Kasvinsky, P. J., Schechosky, S. and Fletterick, R. J. (1978), 
J. Biol. Chem. 253. 9102. 
122. Maurel, P. (1978), J. Biol. Chem. 253, 1677. 
123. Tan, A. W. H. and Nuttall, F. Q. (1975), Biochim. Biophys. Acta 
410, 45. 
132 
124. Dreyfus, M., Vanderbunder, B. and Bue, H. (1980), Biochemistry 
in press. 
125. Chao, J. and Graves, D. J. (1970), Biochem. Biophys. Rés. Commun. 
1398. 
126. Ariki, M. and Fukui, T. (1978), J. Biochem. 183. 
127. Ariki, M. and Fukui, T. (1977), J. Biochem. 78, 1191. 
128. Bunton, C. A. (1977), Pure Appl. Chem. 49, 969. 
129. Warshel, A. and Levitt, M. (1976), J. Mol. Biol. 103, 227. 
130. Firsov, L. M., Bogacheva, T. I. and Bresler, S. E. (1974), 
Eur. J. Biochem. 42, 605. 
131. Hedrick, J. L., Shaltiel, S. and Fischer E. H. (1969) Biochemistry 
8, 2422. 
132. Shimomura, S. and Fukui, T. (1980), Biochemistry 19, 2287. 
133. Beaton, J. R. and Goodwin, M. E. (1954), Can. J. Biochem. Phys. 
684. 
134. Vitamin Bfi Metabolism and Role in Growth (1980), ed. G. P. 
Tryfiates, Food and Nutrition Press, Inc.: Westport, Connecticut, 
377 pp. 
135. Bosron, W. F., Veitch, R. L., Lumeng, L. and Li, T.-K. (1978), 
J. Biol. Chem. 253, 1488. 
136. Spellacy, W. N., Bulii, W. C. and Birk, D. A. (1977), Am. J. 
Obstet. Gynecol. 127, 599. 
137. Adams, P. W., Wynn, V., Seed, M. and Fokard, J. (1976), Lancet 
1, 759. 
138. Brostrom, C. G., Hunkeler, F. L. and Krebs, E. G. (1971), 
J. Biol. Chem. 246, 1961. 
139. Parrish, R. F. and Graves, D. J. (1976), Biochem. Biophys. Res. 
Commun. 70, 1290. 
140. Reimann, E. M., Walsh, D. A. and Krebs, E. G. (1971), J. Biol. 
Chem. 246, 1986. 
141. Bradford, M. M. (1976), Anal. Biochem. 72, 248. 
142. Ahswell, G. (1966), Methods Enzymol. 93. 
133 
143. Glynn, I. M. and Chappell, J. B. (1964), Biochem. J. 90, 147. 
144. McHenry, E. W. (1956), Am. J. Clin. Nutr. 364. 
145. Rhode, P., McCormack, S., Close, L. and Black, A. L. (1980), 
Federation Proc. 39, abstr. 2416. 
134 
OVERALL ACKNOWLEDGEMENTS 
To Donald J. Graves for encouragement, support and assistance. 
His understanding and helpfulness will always be remembered even though 
he may have had reason to doubt It In the past. 
Thanks are also extended to the members of his research group for 
many stimulating discussions. 
